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The objective of the research in this dissertation is to develop microsystem 
based separation technologies for whole cell cancer analysis using human whole 
blood as the input sample.  This research work is carried out with two different 
approaches; one based on a miniaturized cascade magnetophoresis system and a 
second based on dielectrophoresis.  The miniaturized systems can be fabricated using 
MEMS technologies combined with plastic fabrication techniques.   
The design, fabrication, packaging, and characterization of several versions of 
the magnetophoresis and dielectrophoresis microsystems for whole cell cancer 
analysis in human whole blood sample are presented.  Each microsystem consists of 
five elements that are essential for the successful separation and / or manipulation of 
cells.  Those essential components include microfluidic channels, inlet / outlet ports, 
ferromagnetic structures and / or comb-shaped electrodes, a microfluidic interface, 
and system packaging.  For the operation of each microsystem, a blood or tumor cell 
sample is introduced into a device through a tubing and an SLA-based interface.  In 
the magnetophoresis system, the RBCs or the magnetic cells in the sample experience 
a strong magnetophoretic force under a non-uniform magnetic field created by 
external permanent magnets and electroplated ferromagnetic structures.  This allows 
the RBCs to be separated from the nucleated blood cells or the tagged cells to be 
separated from the non-magnetic cells.  In the dielectrophoresis system, cells with 
different dielectric properties experience either positive or negative dielectrophoretic 
force under a non-uniform electric field created by an external AC signal and comb-
 xvii 
shaped electrodes and move from their original positions in a laminar flow pattern to 
different positions.  
The first magnetophoresis microsystem, the six-stage cascade paramagnetic 
mode magnetophoretic separation system, was designed and has successfully shown 
high throughput RBC separation from a human whole blood sample.  The second 
magnetophoresis microsystem was developed for the isolation of malignant cancer 
cells from benign tumor cells and has successfully separated malignant tumor cells 
tagged with magnetic nanoparticles based on their surface expression level of a 
specific protein from benign tumor cells.  Additionally, in an effort to improve the 
throughput of RBC removal from a non diluted whole blood sample, a 
magnetophoresis system with 40 separation stages is proposed and designed.  Two 
dielectrophoresis systems were developed; one dielectrophoresis system tested its 
switching and separation capability based on the native dielectric properties of 
different cell types, while the other investigated the frequency response of different 
cell types by measuring their crossover frequencies in a medium with different 
conductivity.  Additionally, an integrated cascade system contains magnetophoresis 
and dielectrophoresis components is proposed and designed.  
 
 1 
CHAPTER 1  
INTRODUCTION 
 
1.1 Origin and History of the Problem 
1.1.1 Origin of the Problem  
According to the American Cancer Society, cancer accounted for 559,888 
deaths in the United States in 2006 and is estimated to be 292,540 deaths for men and 
259,800 for women in 2009.   This makes cancer the second largest cause of US 
mortality only surpassed by heart disease [1].  The overall cancer incident rate per 
capita has been declining since peaking in early 1990s as a result of cancer prevention 
efforts such as comprehensive tobacco control programs, increased individual and 
community watch for obesity, increased physical activity, and better nutrition, as well 
as increased awareness of the relationship between ultraviolet radiation and skin 
cancer [2].  However, as a result of aging and growth in the US population, the total 
number of cancer deaths set a record high in 2006 [3].  One research study using 
computer simulations found that the lifetime probability of developing cancer is 1 in 
2 for men and 1 in 3 for women [4]. 
Early detection of cancer through regular screening tests provides a better chance 
of successful cancer treatment for patients and has contributed to the decline in the 
cancer related death rate [2].  Moreover treating patients with cancer in the early 
stages would cost much less and help reducing the overall health care cost for the 
individual as well as for the community.  However, regular screening tests using 
conventional cancer detection methods are not readily available for everyone because 
 2 
of the limited resources.  In rural areas, medical experts and facilities for the tests are 
not easily accessible.  Even in urban areas with ample medical resources, the cost 
associated with cancer screening deters many people from having regular screening 




Figure 1.1. Trends in the number of cancer deaths among men and women, US, 
1930-2006. (Graph from [3]). 
 
 
1.1.1.1 Conventional Cancer Analysis Technologies 
Currently, there are several clinical cancer screening methods available for 
different types of cancers.  For example, breast cancer is screened by a regular 
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clinical breast exam and/or a mammogram.  Cervical cancer is detected using a Pap 
test to find abnormal cells from the tissue.  Screening for colorectal cancer is 
conducted using a fecal occult blood test or a colonoscopy.  Screening for lung cancer 
requires a chest x-ray and/or a sputum cytology test.  In screening for prostate cancer, 
a digital rectal exam or a blood test to detect the prostate-specific antigen is usually 
performed [5]. 
Once cancer or suspected cancer is found through simple screening methods, 
more detailed analytic tests are followed for accessing tumor progression, 
heterogeneity, and the effect of drug therapy. 
Conventional non-cell based analytic tools are classified into two sub 
categories, the analysis of DNA/RNA and the analysis of proteins in tumor samples 
and blood from cancer patients.  These analyses are conducted to find the differences 
in the level of DNA damage or genomic alterations in a patient’s tumor sample and/or 
blood sample compared to healthy individuals.  Typical procedures for DNA/RNA 
analysis include PCR / sequencing, and Comet Assay
TM
 for DNA damage assessment 
[6].  For protein analyses [7], there are several techniques such as a Western Blot [8], 
enzyme-linked immunosorbent assay (ELISA) [9], immunohistochemistry (IHC) [10], 
surface-enhanced laser desorption/ionization (SELDI) [11], and matrix-assisted laser 
desorption/ionization (MALDI) time of flight mass spectrometry (TOF-MS) [12].   
1.1.1.2 MicroSystem-Based Cancer Analysis Technologies 
Miniaturization of these analytic tools has various advantages such as a 
shorter analysis time, a smaller sample size, less reagent volume required for analysis, 
and especially an integrated understanding of the biological system by studying 
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multiple components simultaneously [13, 14].  Microfluidic based PCR chips have 
been developed by a number of groups, which enable cost and time savings with 
smaller volume and faster thermocycling rates [15, 16].  Chip based mass 
spectrometry has been demonstrated by several groups as well [17, 18].  Also, 
microarray technologies have been applied to detect and analyze a protein or multiple 
protein interaction in a single experiment [19~22].   
1.1.1.3 Whole Cell Based Cancer Analysis Technologies 
Cell based cancer analysis is another important analytic methods in detecting 
cancer and monitoring the stages of cancer progression.  Determining the density of 
circulating tumor cells (CTCs) in blood is a good example of cell based cancer 
analysis.  CTCs are known to be the tumor cells in blood derived from the clones in 
primary tumors.  CTCs can be found in patients even before a primary tumor is 
detected with conventional clinical screening methods.  Thus detecting CTCs in blood 
can be used as an early detection methodology for cancer.  Moreover, the density of 
CTCs in blood has been shown to directly correlate with the progression of cancer so 
that determining the level of CTCs in blood can be helpful in characterizing genetic 
and immunophenotypic changes with tumor progression [23]. 
One of the most widely used macroscale cell analysis systems is fluorescence 
activated cell sorting (FACS) based on immuno-fluorescence.  FACS was invented in 
the late 1960s by Bonner et al. and commercial machines became available in the 
early 1970s [24].  Currently, more than 30,000 FACS instruments are used in 
thousands of laboratories throughout the world [25].  For cell separation with FACS, 
the cells are stained with fluorescent dyes through specific antibody-antigen bonding 
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chemistries and confined to a column of liquid.  The cell suspension is injected 




Figure 1.2. Diagram of modern three-laser FACS with multiple detectors. 




The stained cells in the stream emits a fluorescent pulses during laser beam 
illumination.  A Photodetector detects and analyzes the emitted light and generates a 
charging pulse.  The charging pulse induces a charge in the stream while the droplets 
that contain targeted cells break off from the stream.  Finally, the charged droplets are 
deflected and separated in an electrostatic field.  Recent advances in fluorescent dye 
techniques enable FACS to separate more than 10 different types of cells 
simultaneously [25].  Although FACS can separate biological cells efficiently with 
high accuracy, high equipment and operation costs, the requirement of trained 
personnel to operate the system and long preparation time for labeling samples hinder 
macroscale FACS from being suitable for clinical point-of-care devices [26, 27]. 
 Density gradient centrifugation is a cheaper and easier-to-operate alternative 
for cell separation.  In batch density gradient separations, the mixture of diverse cells 
is layered on top of a density gradient in a tube and the tube is subjected to 
centrifugation.  The different types of cells pass through the density gradient at 
different rates depending on their sizes and shapes and appear as distinct bands in the 
gradient.  Recently Ito et al. have demonstrated a continuous flow density gradient 
separation using a centrifuge bowl with a single circular channel [28]. 
In continuous flow density gradient separation, a set of different density media 
is continuously introduced through five outer inlets, while the sample suspension is 
injected through one inner inlet.  Centrifugal force combined with drag force 
distributes the cells into corresponding density layers and the distributed cells are 
separated into six different outlets [28, 29].  For precise sub-classification of cells, the 
media’s density gradient should be close to that of the different target cells.  Although 
 7 
density gradient centrifugation is a simple and cheap option for cell separation, it 
requires recovery of the separated cells from the density gradient media.  
Microenvironment alteration around the cells during the recovery process is an issue 




Figure 1.3. Whole cell separation using centrifugation: batch density gradient 
separation and continuous density gradient separation. (Image from [28]). 
 
 
Filtration through micro-pores is another easily accessible option in separating 
cells using their size differences, but clogging issues during the separation process 
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make this only suitable for a batch type separation system.  Tangential flow filtration 
enables continuous separation of mixed particles through precise control of trans-
membrane pressures and feed flow rates [30]. 
Magnetically-activated cell separation (MACS) is another widely used 
macroscale cell based analysis technology using magnetophoretic force as a driving 
force.  MACS will be covered in more detail in Chapter 2.   
1.1.1.4 MicroSystem-Based Whole Cell Cancer Analysis Technologies 
Microfabricated bioanalytical devices have existed for approximately 40 years 
and achieved several commercial and scientific successes [31].  The ability to design 
and control experiments using microfabricated devices has attracted attention in 
biological applications [32, 33].  Microfluidic cell preparation systems in particular 
have received much attention among researchers because of their small device size, 
high surface-area-to-volume ratio, high throughput, etc [34~36].   
In many instances, miniaturization of cell separation systems helps increase the 
magnitude of generated forces, such as dielectrophoretic or magnetophoretic forces 
on biological cells [34].  The larger forces along with the fact that the dimensions of 
the separation system are comparable in size scale to the biological cells enable more 
effective separation of target cells.  Temperature control is critical in cell experiments 
and high surface-area-to-volume ratio in microfabricated systems enhances heat 
dissipation that reduces the risk of significant temperature rise during experiments 
[34].  Moreover, the ability to perform biological experiments efficiently with only a 
small amount of complex fluids and without the need for an expert operator makes 
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microfluidic systems promising candidates for point-of-care devices in resource-




Figure 1.4. Hydrophoretic filtration by slanted obstacles and filtration obstacles. 
(Image from [41]). 
 
 
Various microfluidic separation systems have been developed utilizing diverse 
cell properties as the separation mechanism.  Using differences in cell size and 
deformability, neuroblastoma tumor cell separation from whole blood was 
demonstrated with sieving structures with different gaps [40].  Choi et al. have shown 
continuous separation of white blood cells (WBCs) from red blood cells (RBCs) by 
hydrophoretic filtration with a microfluidic device composed of slanted obstacles and 
filtration obstacles [41].  A microstep device was developed to separate bacteria cells 
by shear-driven backward flow that avoids possible blockage of the filter by larger 
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cells [42].  Yamada et al. have demonstrated size-dependent separation in a 
microfluidic device employing effective flow manipulation based on the concept of 
hydrodynamic resistance in microchannels [43]. 
Suspended particles exposed to an ultrasonic standing wave field in 
microfluidic channels are affected by an acoustic radiation force and forced to move 
toward either pressure nodes or pressure antinodes, depending on the density and 
compressibility of the particles and media [44].  Continuous separation of mixed 
particles in a suspending media into multiple outlet fractions was demonstrated with 
laminar flow and acoustic standing wave forces in microfluidic channels [45~47].  
Petersson et al. have shown the continuous separation of RBCs, WBCs, and platelets 




Figure 1.5. Operation principles of free flow particle separations by 




 Microparticles or cells can be guided by optical gradient forces without any 
physical contact in a microfluidic channel, depending on the refractive index and the 
size of the particle, as well as the focusing laser power, fluid flow velocity, driving 
force direction, and optical lattice geometrical parameters.  Various continuous flow 
cell manipulation systems using optical gradient forces have been demonstrated 
[49~54].  MacDonald et al. have demonstrated continuous fractionation of cells 
within a passive optical lattice, where cells experience different guiding affinity 
depending on their refractive index and size [55].  Applegate et al. have shown optical 




Figure 1.6.  Micrograph of particle separation by optically induced flow 
cytometry. (Image from [53]). 
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In presence of a high magnetic field gradient, microparticles or cells with 
different magnetic susceptibilities can be separated by magnetophoresis.  Microfluidic 
magnetophoresis systems will be covered in more detail in Chapter 2, 3, and 4.  
Biological cells or particles with different intrinsic dielectric affinity can be 
separated in a non-uniform electric field by varying the frequency of an applied 
alternating current (AC) source.  Depending on their dielectric affinity and the 
applied electric field frequency, some cells experience attractive force in the direction 
of electric field gradient and others experience repulsive force in the opposite 
direction of applied field gradient.  Microfluidic dielectrophoresis systems will be 
covered more in detail in Chapter 5, 6, and 7.   
One major challenge in detecting the level of targeted rare cancer cells or 
CTCs in blood comes from the fact that human whole blood is a heterogeneous 
mixture of diverse blood cells and 98 % of blood cells are RBCs whose cell density is 
around 5 × 10
9
 cells per milliliter and usually the cell density of CTCs in peripheral 
blood ranges from 0~1 cells per milliliter, which is extremely low compared to that of 
RBCs.  This requires extremely precise identification and separation of CTCs from 
whole blood samples.  Another challenge arises from the characteristic of blood that it 
responds quickly to small changes in environment and can be easily altered during the 
separation and identification process.  Due to these challenges, separating and 
monitoring the level of targeted rare cells in blood has not been quite successful with 
miniaturized cell analysis systems. 
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1.2 Objective: Develop a Continuous Flow Separation and Manipulation 
System for Cancer Cell Isolation from Human Whole Blood using 
Microfabrication Technologies 
The objective of my research was to develop microsystem based separation 
technologies for whole cell cancer analysis using human whole blood as the input 
sample.  Two different approaches have been demonstrated; one based on a 
miniaturized cascade magnetophoresis system and a second based on 
dielectrophoresis that enables efficient and novel separation of targeted rare cells 
from human whole blood fabricated using MEMS technologies combined with plastic 
fabrication techniques.  Continuous flow magnetophoresis will be used as an 
enrichment device for separating and removing most RBCs from a human whole 
blood sample, while concentrating targeted rare cells and other nucleated blood cells.  
Integrated, continuous flow dielectrophoresis will be demonstrated as an isolation 
device for separating targeted rare cells from other nucleated cells and residual RBCs.  
The research was organized into three specific aims.  Furthermore, each 
specific aim was divided into a series of sub-aims.   Three specific aims with the 
corresponding sub-aims are as follows. 
 
Specific Aim #1: Develop a microfluidic separation system using magnetophoresis to 
separate blood cells and targeted rare cells. 
 Subaim 1.1: Develop a cascade type continuous flow magnetophoretic 
microseparator for blood cell separation in diluted blood without magnetic tagging. 
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 Subaim 1.2: Develop a magnetophoretic microseparator for specific cancer 
cells depending on the expression level of proteins on the cell surface. 
 Subaim 1.3: Develop a continuous flow magnetophoretic microseparator for 
blood cell separation in whole blood without magnetic tagging. 
 
Specific Aim #2: Develop a microfluidic separation system using dielectrophoresis to 
separate blood cells and targeted rare cells. 
 Subaim 2.1: Characterize the dielectrophoretic responses of blood and 
head/neck cancer cells in the buffer solution with different conductivity. 
 Subaim 2.2: Develop a continuous dielectrophoretic microsystem for blood 
cells manipulation and separation. 
 Subaim 2.3:   Develop a continuous dielectrophoretic microsystem for 
head/neck cancer cells separation. 
 
Specific Aim #3: Develop microfluidic interfaces and packages for improved sample 
introduction and stable experiments. 
 Subaim 3.1: Develop microfluidic interfaces for each microsystem using 
plastic fabrication techniques for interconnecting the macro world with the 
microfluidic devices. 
 Subaim 3.2: Develop system level packages for each microsystem using 
plastic fabrication technique for reliable experiments. 
 
Specific Aim #4: Integrate magnetophoretic and dielectrophoretic microsystems into 
a single microfluidic system for rare cell separation from human whole blood. 
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1.3 Overview of the Thesis and What Each Chapter Entails 
Chapter 1 of this dissertation includes the origin and history of the problems 
in rare cell separation from human whole blood for detecting and monitoring cancer.  
The research objectives are also presented in Chapter 1.  Chapter 2 presents the 
details of magnetophoresis systems including the theoretical background, design 
consideration, and two applications using the magnetophoretic microsystem.  Chapter 
3 presents the development of the magnetophoresis microsystem for blood cell 
separation using their native magnetic properties.  A six stage cascade 
magnetophoretic microsystem was developed and characterization results are 
presented in Chapter 3.  The application of magnetophoresis microsystem for cancer 
cell separation based on the surface expression level of target proteins is presented in 
Chapter 4.  A three stage cascade microfluidic device is developed and 
characterization results along with sample preparation steps are presented in Chapter 
4.  Chapter 5 describes in detail about the dielectrophoretic separation systems with 
their theoretical and historical background, and brief introduction of their applications 
for blood and cancer cells separation.  Chapter 6 presents the development of the 
dielectrophoresis microsystem for blood cell stream manipulation and separation 
using their native dielectric properties.  The application of a dielectrophoresis 
microsystem for cancer cell separation and characterization is presented in Chapter 7.  
Finally Chapter 8 describes the development of proposed forty stage whole blood 
separator and integrated microfluidic system of magnetophoresis and 
dielectrophoresis for target rare cell separation from human whole blood.  Chapter 9 
summarizes the overall research results and describes future works.  
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Magnetic force has been utilized over thousands of years and uses can be 
found from small refrigerator magnets to huge power plant generators.  If focused on 
the application of magnetic force to the separation of particles, high gradient 
magnetic field separation (HGMS) has been shown to be an effective method for 
removal of metals or radioactive particles from waste fluids and gases in macro scale 
industrial applications [57, 58].   
The magnetophoretic force experienced by a particle suspended in a fluid 
arises from a change in the magnetic energy in the system.  Magnetic energy density 
in a linear isotropic medium is expressed as HB
2
1
, where H  and B  represent a 
magnetic field intensity and magnetic flux density respectively, and the magnetic 
energy in a suspending fluid with a susceptibility of Fχ  enclosed in a volume PV  can 






HVVHB PFPF µ= , where HB FF µ= and )1( FOF χµµ += .  (2.1) 
If a particle with a volume PV  and susceptibility of Pχ  is placed inside the fluid, the 












HVHVVHBVHBU PFPOPFPPFPP χχµµµ −=−=−= .  (2.2) 
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The magnetic force associated with this magnetic energy change can be calculated by 




HVF POm ∇= χµ
r
, where FP χχχ −= . (2.3) 
From Equation 2.3, magnetic force can be viewed as a product of PVχ , which 
represents physical properties of a target particle and )( 2H∇ , which reflects the 
magnetic field properties surrounding a particle.  Effective separation of weakly 
magnetic particles that show small differences in magnetic susceptibility from the 
suspending fluid requires a considerable increase either in the magnitude of magnetic 
field intensity, H , which usually can be achieved by using more powerful external 
magnetic source or in the magnitude of H∇  [59].  
A uniform external magnetic field generated by an external permanent magnet 
becomes inhomogeneous around ferromagnetic structures because of the appearance 
of magnetic polarity on the ferromagnetic wires.  A resultant, magnetic field gradient 
is created near the ferromagnetic structures.  The magnetic field gradient reaches a 
maximum if ferromagnetic structures are placed in a way such that the axis of wires is 
always perpendicular to the direction of external magnetic field.  High gradient 
magnetic field separation, HGMS, uses this magnetic field gradient and is a powerful 
method in the separation of micron-sized, weakly magnetic particles. 
Various HGMS systems have been demonstrated for biological applications, 
such as the purification of proteins [60], the extraction of synthesized organic 
compounds from water [61], magnetic sorting or extraction of cells [62, 63], and 
locally targeted drug delivery [64~66].   
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2.2 Macroscale Magnetophoresis Systems 
One of widely used macroscale magnetophoresis separation system is 
magnetically activated cell separation (MACS).  MACS technology was 
commercialized in the late 1980s by Miltenyi et al. and its enrichment capability has 
been shown in various studies [67~69].  For cell separation with MACS technology, 
target cells are labeled with superparamagnetic microbeads by antibody-antigen 
immunoreactions and the labeled cell suspension is placed inside a column with a 
ferromagnetic mesh.  The column is positioned between strong permanent magnets 
and a high gradient magnetic field is induced on the column matrix so that target cells 
labeled with magnetic microbeads are retained in the column by magnetophoretic 
force, while the unlabeled cells are eluted by a buffer solution.   
 
Figure 2.1. Magnetically Activated Cell Sorting (MACS) system. (Picture from 
[72]). 
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Commercially available magnetic microbeads for current MACS technology 
are composed of a biodegradable matrix; thus the additional detachment process 
needed to remove the microbeads from the target cells after the separation process 
becomes unnecessary.  Although MACS technology provides a gentle and fast 
enrichment method in cell preparation with simpler operational procedures than 
FACS, it still requires a discontinuous sample preparation step for labeling the 
samples with magnetic beads and removing the microbeads from the cell media after 
the separation [70~74]. 
It has been reported that in whole blood, deoxyhemoglobin RBCs have a much higher 
magnetic susceptibility than other biological cells and can be treated as paramagnetic 
particles, while WBCs or other nucleated cells behave like diamagnetic particles [75].  
Using their native magnetic properties, RBCs, WBCs, and other rare circulating cells 
in human whole blood can be separated using high magnetic flux gradients [76~78]. 
Takayasu et al. have developed a macroscale continuous magnetic separator 
and demonstrated the separation of blood components from whole blood based on 
HGMS and a gas-permeable membrane with nitrogen gas [79].  The magnetic 
separator has 3.6 m flow length and the flow channel was made of plastic tubing and 
co-wound with a ferromagnetic wire on a Plexiglass tube.  As a blood sample passes 
through the flow channel, depending on their magnetic properties, the blood 
components are separated into three different outlets.  However, because of its 
macroscale size combined with the small magnetic susceptibilities of the blood 
components, the continuous magnetic separator required very high external magnetic 
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source over 2 T for the separation of blood components from whole blood 
continuously.  
 
2.3 Microscale Magnetophoresis Systems 
2.3.1 Brief Introduction of Magnetophoresis 
Unlike macroscale systems that require a huge external magnetic field to 
create a high magnetic field gradient on biological cells, microfluidic 
magnetophoresis systems can create a high magnetic field gradient with a much 
smaller external magnetic field; thus small permanent magnets can be used, reducing 
the overall size of the whole separation system [80].  Various microfluidic 
magnetophoresis systems have shown the ability to separate out RBCs efficiently 
from whole blood samples, thus isolating nucleated cells for further analysis [77, 78, 
81]. 
In a high gradient magnetic field, blood cells experience an attractive or 
repulsive magnetophoretic force depending on their native magnetic properties.  The 









































=  (2.4) 
where Oµ , Bµ and Wµ  are the magnetic permeabilities of the air, the buffer solution, 
and the ferromagnetic structures, respectively; OH  is the external magnetic field 
intensity; BCχ  and Bχ  are the magnetic susceptibilities of the  blood cell and the 
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buffer solution; )( BBC χχχ −=∆  is the relative magnetic susceptibility of the blood 
cell with respect to the buffer solution; BCV  is the volume of a blood cell; a  is the 
radius of a circular ferromagnetic wire; r  and ϕ  are cylindrical coordinates for 




are unit vectors for distance and angle in 




Figure 2.2. A high magnetic field gradient is generated in the region (A) around 
the ferromagnetic structures using permanent magnets as the field source. The 
RBCs are attracted toward the ferromagnetic capture structures by the 
paramagnetic force created by the magnetic field gradient. 
 
 
From the Equation 2.4, when magnetic particles are placed on the x-axis or in 
the microfluidic channel as shown in Figure 2.2 ( ϕ ≈ 0º or 180º, 
,02sin ≈ϕ 12cos ≈ϕ ), magnetic particles whose χ∆  is positive (paramagnetic 
particles) are attracted toward the ferromagnetic structures where the magnetic field 
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gradient becomes higher, while those that have negative χ∆  are pushed away from 
the ferromagnetic structures.  Deoxyhemoglobin RBCs have a positive χ∆  in most 
buffer solutions, so they are attracted toward the ferromagnetic capture structures by 
the paramagnetic force. 
 
2.3.2 Advantage of Magnetophoresis Compared to Other Microsystem in 
Manipulating Blood and Cancer Cells 
2.3.2.1 Reason for Chosen as Driving Force in Proposed System 
Human whole blood consists of 45 % blood cells and 55 % plasma with 98 % 
of the blood cells being RBCs, whose cell density is around 5 × 10
6
 cells/µL [83].  
The number of specific rare cells in the blood stream contains valuable information 
about the human body.  For example, the density of the circulating tumor cells 
(CTCs) in blood has shown to directly correlate with the progression of cancer.  The 
number of CTCs introduced daily into the blood stream from one gram of tumor 
tissue is about 1 × 10
6
, but the number of epithelial cells in blood from a person 
without any known cancer is very low and almost never exceeds one cell per 7.5 mL 
of blood [23, 84, 85].  The cell density of rare cells is extremely low compared to that 
of normal blood cells such that separating targeted rare cells other than normal RBCs 
in human whole blood without any microenvironment alteration has been a challenge 
in the development of integrated microfluidic analysis systems using whole blood as 
input samples.  The removal of RBCs from whole blood samples in the early stages of 
a blood sample preparation would greatly help downstream sub-classification, 
analysis, and treatment of targeted rare cells.  By using magnetophoresis as a driving 
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force, this task can be carried out most effectively without the need for complex 
intercellular tagging procedures.  
In the development of a magnetophoretic microseparation system, several key 
design and operation factors should be considered.  The first consideration should be 
given to the relative position of the external magnetic field source and the 
microseparator system.  From the Equation 2.4, when the microfluidic channels, 
which the magnetic particles are flowing through, are placed on the axis where ϕ  ≈ 
0º or 180º, ( ,02sin ≈ϕ 12cos ≈ϕ ), particles whose χ∆  is positive (paramagnetic 
particles) are forced (captured) toward the dense magnetic field area (close to 
ferromagnetic structures), while particles that have negative χ∆  are pushed away 
toward the coerce magnetic field area.  This mode of operation is called as the 
paramagnetic capture mode (Figure 2.3 (a)).   
In a complimentary mode of operation, when the microfluidic channels are 
placed on the axis where ϕ  ≈ 90º or 270º, ( ,12sin ≈ϕ 02cos ≈ϕ ), diamagnetic 
particles are captured toward the ferromagnetic structures, while paramagnetic 
particles are forced away from the ferromagnetic structures.  This mode of operation 
is called as the diamagnetic capture mode (Figure 2.3 (b)).  These two operation 
modes can be used interchangeably in one magnetophoretic microseparator by simply 








Figure 2.3. Working principle of the paramagnetic capture mode operation and 
the diamagnetic capture mode operation. (Images from [77, 86]). 
 
 
Having multiple separation stages in a microfluidic chamber can enhance 
separation efficiency compared to having a single wire.  Previously, blood cell 
separations were carried out with a single stage and a three stage ferromagnetic 
structures and the characterization results showed that the three stage design was 
capable of higher throughput with improved separation efficiency.  Even though 
increasing the number of separation stages could be helpful in terms of throughput 
and separation efficiency, there are restrictions in increasing the number of separation 
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stages.  With the same external magnetic source, there is a minimum time required for 
capturing target cells that dictates the minimum length of each separation stage.  
Therefore, the overall length of the separation chamber should be increased as the 
number of separation stages is increased.  This would result in added sample retention 
time, which is the time period for the input sample to travel from the inlet to the outlet 
of the system.   
In separating targeted magnetic cells, there are two major driving forces 
utilized in the separation process.  These two driving forces are the, magnetophoretic 
force created by external magnetic sources and the drag force created by the 
interaction of magnetically forced cells in the fluid flow.  For a magnetophoresis 
microsystem to separate target particles continuously, the balance between the two 
forces should be considered carefully in designing the microsystem and the packaging.  
Usually, as the magnitude of a magnetophoretic force becomes greater, the required 
capture time for separating target cells shortens.  However, the possibility of target 
particles being held inside the separation chamber also increases unless the drag force 
on the target cells becomes proportionally higher.  This balance can be controlled by 
changing the sample flow rate, the distance between the external magnetic source and 
the microseparator channel, and the magnitude of external magnetic source.  However, 
when the target cells consist of magnetic cells with similar but different levels of 
magnetic susceptibility, this balance control for continuous mode separation becomes 
extremely difficult and the separation efficiency would be lowered with continuous 
mode separation.  For these cases, another method of operation, Hold and Release, is 
preferable to continuous mode separation.  In the hold and release mode operation, 
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the target cells with a higher magnetic susceptibility are captured and held on the 
ferromagnetic structures in the separation channel during a ‘hold phase’ with the use 
of external magnetic sources and released into capture outlet during a ‘release phase’ 
with a small or no external magnetic source.. During the hold and release operation, 
other groups of targeted cell types with a lower magnetic susceptibility can be 
separated into a collection channel if the drag force of the other cells in the fluid is 
great enough to overcome the magnetophoretic forces used to ‘hold’ the cells with the 
higher magnetic susceptibility.  The targeted cell types with the lower magnetic 
susceptibility are separated as in the continuous mode operation.    
 
2.4 Applications of Microscale Magnetophoresis Systems 
In this work, two magnetophoretic separation systems were developed and 
characterized.  The first magnetophoretic microsystem was developed for high 
throughput blood cell separation.  This microsystem uses a six stage cascade style 
paramagnetic capture mode to separate the blood cells effectively.  The development 
and characterization of the magnetophoretic microsystem is presented in detail in 
Chapter 4.  Another magnetophoretic microseparator system using three stage 
paramagnetic capture mode was developed for determining the heterogeneity of 
head/neck cancer cells based on the surface protein expression level of target cancer 





CHAPTER 3  
 MAGNETOPHORESIS SYSTEM APPLICATION I 
(High Throughput RBC Removal from a Blood Sample) 
 
3.1 Introduction 
Human whole blood consists of 45 % blood cells and 55 % plasma with 98 % 
of the blood cells being RBCs with a cell density of around 5 × 10
6
 cells/µL [83].  On 
the contrary, the cell density of rare cells such as CTCs is extremely low compared to 
that of normal blood cells; thus separating target rare cells other than normal RBCs in 
human whole blood without any microenvironment alteration has been a challenge in 
the development of integrated microfluidic analysis systems using whole blood as 
input samples.  The removal of RBCs from whole blood samples in the early stage of 
a blood sample preparation would greatly help the downstream sub-classification, 
analysis, and treatment of target rare cells.  By using magnetophoresis as a driving 
force, this task can be carried out most effectively without complex intercellular 
tagging procedures.  
 
3.2 Magnetic Microseparation System Design 
Previously proposed paramagnetic microsystems for blood cells separation 
[77] have shown high separation efficiency of 93.5 % for RBCs and 97.4 % for 
WBCs at a volumetric flow rate of 5.0 µL/hr corresponding to 2.5 × 10
6
 cells/hr.  
However, the separation efficiencies decreased to 75 % and 65 % as the volumetric 
flow rate increased to 20 µL/hr and 30 µL/hr, which hindered its application to fast 
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processing of small volumes of blood sample (~ 5 µL) from the finger tip or a cotton 
swab, etc. 
To increase the volumetric flow rate while maintaining high separation 
efficiency, a new magnetophoretic microseparation system design is required.  The 
most important factor considered in the design of new magnetophoretic system was 
the required trapping time for the RBCs to move from position (x1, y) to position (x2, 























































































where Oµ  is the magnetic susceptibility of the air; η  is the apparent viscosity of the 
blood cells in the buffer solution; A  is the maximum cross-section area presented 
perpendicular to the velocity; l  is the characteristic length of the blood cell in the 
direction of velocity vector; χ∆  is the relative magnetic susceptibility of a blood cell 
relative to the buffer solution; BCV  is the volume of the blood cell; SM  is the 
saturation magnetization field of the rectangular wire; OB  is the external magnetic 
flux; and a  is the radius of the circular ferromagnetic wire or half height of 
rectangular wire. 
The first design variable considered was increasing the number of separation 
stages.  By increasing the number of separation stages, already captured RBCs would 
be swept into the collection channel, giving more space for the remaining RBCs to be 
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attracted the ferromagnetic structures, thus increasing the separation efficiency.  Thus 
for similar separation efficiency, the required effective trapping time can be decreased.  
However, the number of separation stages can not be increased indefinitely.  To move 
RBCs from one point in the main channel to the other point where cells can be swept 
into collection channel, RBCs should be exposed to the lateral magnetophoretic 
forces for a certain amount of time (trapping time) as described in Equation 3.1.  If 
the size of glass slide, on to which the microseparation system is fabricated, is limited, 
the more separation stages there are, the shorter each stage would be making the 
resident time shorter than the required trapping time at a specific volumetric flow rate.  
In this work, the total length of the main separation chamber was chosen to be 48 mm.  
For the unretained cells to pass through the separation chamber within 5 minutes, the 
average cell flow velocity should be higher than 0.16 mm/s.  To achieve the 
volumetric flow rate of 20 µL/hr or higher with the fore-mentioned cell flow velocity, 





The channel depth was chosen to be 100 µm considering the available fabrication 
process.  The required trapping time for RBCs at 70 µm away from the ferromagnetic 
structures to move to 20 µm away from the wires was calculated to be 35 seconds.  
Considering both the trapping time and the minimum average flow rate, each 
separation stage should have a length of 5.6 mm or longer.  The actual length of the 
separation stages was chosen to be 8.0 mm; thus the total number of separation stages 
was increased to six.   
The second design option was increasing the cross sectional area of each main 
channel.  In the previous paragraph, the microchannel depth was chosen to be 100 µm.  
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 cross sectional area, the channel width should be 
increased up to 200 µm.  However, those cells initially positioned further away from 
the ferromagnetic structures than 100 µm would be hard to be captured effectively.  
To overcome this limitation, the channel width of first separation stage was chosen to 
be 200 µm, but after each separation stage, the width was decreased down to 180 µm, 
160 µm, 140 µm, 120 µm, 100 µm, and 100 µm by making the width of 
ferromagnetic structures wider at each of the subsequent stages.  
Because the number of collected RBCs in the center channel is far more than 
that of cells in the side channel after six stages, some collected RBCs can backflow 
into the two outer side channels and side channel outlets by diffusion.  Thus, in this 
work, the three outlet channels (two side outlet channels, one center outlet channel) 
were designed as isolated flow channels to increase the overall separation efficiency 
of the system. 
The overall design and operational concept of six stage cascade paramagnetic mode 




Figure 3.1. Operation of the PMMS system. 
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 As shown in Figure 3.1, the whole blood sample entered the PMMS system 
and was subsequently divided into two outer microchannels flowing parallel to the 
ferromagnetic structures.  The RBCs were attracted to the ferromagnetic structures by 
the force produced by the magnetic field gradient and forced into the center 
microchannel, while WBCs and other rare cells were forced outward and travel along 
the two outer channels.  The fluid channel network were designed so that only the 
RBCs forced to the edge of the ferromagnetic capture structure were swept into the 
center channel, while other cells in the flow stream had a low probability of being 
swept into the center channel.  The remaining RBCs in the outer channels were 
attracted and separated into the center flow channel at the subsequent separation 
stages.  By combining six separation stages in a cascade mode, the RBC level in the 
outer channel was reduced stage by stage and after six separation stages, the RBCs 
were removed from the flow stream in the two outer channels. 
The magnetophoresis system for blood cell separation requires two 
photolithography steps.  The two mask designs for microfluidic channel and 
ferromagnetic structures are shown in Figure 3.2. The distance between the separation 
chamber and the inlet hole was increased to provide a better image of the separation 
chamber area during the experiments, since the microfluidic interface for the inlet 
required minimum spaces for bonding and those bonded area became obscure. 
The mask designs were initially drawn and saved in DXF file format by 
Autodesk® AutoCAD and later converted into DWM format using ASM 2500W (Art 
Work Conversion Software, Inc., Santa Cruz, CA, USA) for the pattern generator.  
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The converted files were sent to Georgia Tech Microelectronics Research Center 





Figure 3.2. Mask design for microfluidic channel (a) and electroplated 









3.3 Microsystem Interface and Package Design 
The microfluidic separation system required microfluidic interfaces to 
introduce the blood samples into the microsystem and to collect the separated target 
cells, and system packaging to protect and stabilize the microsystem during 
experiments.  For this purpose, the plastic fluid interfaces and packaging were 
fabricated utilizing stereolithography (SLA) technology and assembled with rubber 
O-rings to provide reliable fluid interconnection and sealing between the microsystem 
and macro experimental instruments, Figure 3.3 [87].  The cylindrical structures 
represent the area for holding the capillary tubing.  The “[” shaped edge was to 
provide space for the tip holder of system packaging (to hold the microfluidic system 
while conducting the experiments). 
A cross-sectional view of the fluid interconnection part of the designed 
interfaces is shown in the bottom figure of Figure 3.3.  The lower O-ring was attached 
to the bottom part of the SLA interface to prevent the overflow of ultra violet (UV) 
cure adhesive resin into the inlet ports during the bonding process between the SLA 
parts and the glass substrates.  The upper O-ring was inserted after the SLA 
fabrication process to hold the capillary tubing firmly in place during experiments.  
The capillary tubing was used to interface the macroscale fluid delivery system to the 










Figure 3.3. Design of the microfluidic interface (top) and a cross-sectional view 




The system packaging for the magnetophoretic separation system was 
composed of two side pockets to hold the permanent magnets and one center stage to 
place and hold the assembled microsystem.  The system packaging designs are shown 
in Figure 3.4.  The system package was designed such that the permanent magnets 
could be positioned to create a magnetic field perpendicular to the sample flow inside 
the microseparator.  Open cavities in the system package under the microchannel area 
were used to enable monitoring of the blood cell movement during separation by 




Figure 3.4. Design of the magnetophoretic separation system packaging. 
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The overall size of the system packaging is 105 mm × 65.0 mm × 21.5 mm 
(length × width × height).  The width of center stage for microsystem was chosen to 
be 21.0 mm (1 mm larger than microfluidic chip width) and the width of side pocket 
was chosen to be 16.5 mm. 
For the drawing of the microfluidic interface and system packaging, Solid 
Edge® program was used and the design was saved as STL file format which is 
native to the stereolithography CAD software created by 3D Systems®. 
 
3.4 Microsystem Fabrication and Packaging 
The separation channel of the PMMS system consisted of microfluidic 
channels, ferromagnetic structures and microfluidic interconnections.  The overall 
fabrication process is shown in Figure 3.5.  
In the fabrication of the separation system, a 500 Å chromium (Cr) layer and a 
2000 Å gold (Au) layer were sputtered on both sides of a Schott Borofloat glass 
substrate (SB-1, S. I. Howard Glass Co., Inc., Worcester, MA, USA) using a Unifilm 
direct current (DC) sputter (PVD-300, Unifilm Technology, LLC., Boulder, CO, 
USA).  Positive photoresist was spin-coated at 5000 rpm for 30 seconds on the front-
side of the glass substrate and soft baked in a vacuum oven at 120 ºC for 1 minute.  
The microfluidic channel was patterned through UV light exposure using the OAI 
Mask Aligner (Optical Associates, Inc., San Jose, CA, USA) and developed.  The 
back side and perimeter edges of the substrate were coated with positive photoresist 
and hard baked in a vacuum oven at 120 ºC for 5 minutes.  The exposed Cr / Au 
layers on the front side were subsequently etched in Cr and Au etchant, and a 100 µm 
 37 
deep microchannel was realized by hydrofluoric wet etching of the glass for 70 
minutes (Figure 3.5(a)).  The microchannel pictures after glass wet etching process 








Figure 3.6. Etched microchannel in the glass substrate. 
 
 
After removing the photoresist and metal masking layers, 150 Å, 1500 Å, and 
1000 Å titanium / copper / chromium electroplating seed layers were sputtered over 
the surface of the etched glass substrate using the Unifilm DC sputter.  Thick 
photoresist was spin coated at 300 rpm over the surface of the etched glass substrate, 
resulting in a measured thickness of photoresist over the 100 µm deep microchannel 
area of 130 µm.  The substrate with uncured photoresist on the top surface was 
planarized by leaving it on a flat, level surface for 30 minutes before soft baking.  
Afterwards, the substrate was soft baked on a hot plate at 110 ºC for 20 minutes.  The 
ferromagnetic capture structure electroplating molds were patterned by UV light 
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exposure using the Karl Suss MA-6 Mask Aligner (Karl Suss America, Inc., 
Waterbury Center, VT, USA) and development in photoresist developer (Figure 3.5 




Figure 3.7. The mold for electroplating is patterned inside the microchannel. 
 
 
The ferromagnetic capture structures located within the patterned flow 
channel, 100 µm thick, were realized by electroplating nickel iron (NiFe) permalloy 
using a Ni81Fe19 electroplating bath [88] on the pre-defined seed layer after removing 
the exposed Cr layer.  The electroplating process was carried out at room temperature 
with a current density of 20 mA/cm
2
.  Following the electroplating process, the thick 
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photoresist molds and seed layers were removed by chemical etching, resulting in the 
patterned ferromagnetic structures within the microfluidic channel network (Figure 












 stereolithography system (3D Systems, Co., Rock hill, SC, 
USA) was used to fabricate a drilling guide, microfluidic interfaces, and the system 





 system by a Lightyear® program that can control the number of 
parts to be built and the supporting structures for each part.  The converted file was 




 system and a build was started using a linked computer 
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system in rapid prototyping manufacturing and manufacturing institute (RPMI) labs 
at Georgia Tech.  The typical UV laser power for SLA process was 100 mW.  The 
fabrication time were mostly determined by the height of tallest part.  With a 100 mW 
power, a build time for the system package was around 4 hours.  After the build for 
SLA parts was completed, they were cleaned by isopropyl alcohol in a ultrasonic bath 
for 15 minutes and rinsed again with flowing isopropyl alcohol.  The cleaned parts 
were baked in UV oven for 30 minutes.  The drilling guide was used to enable correct 
positioning of the inlet and outlet ports in the top glass substrate.  The drilling guide 









  The inlet and outlet holes were defined in the blank top glass using a 1.0 mm 
diameter diamond drill bit.  The drilled top glass was aligned and thermally bonded 
with the patterned bottom glass in a box furnace at 685 °C for 3.5 hours in a nitrogen 
gas environment (Figure 3.5 (d)).  Finally, the SLA-based microfluidic interface was 
bonded to the microseparator using a UV curable resin (Renshape® SL 5510, Vantico 
A&T US, Inc. Lansing, MI, USA) between the glass microfluidic system and the 
SLA interface.  The resin was cured using UV light exposure for 30 minutes (Figure 
3.5 (e)). 
During the fabrication process for the PMMS system, there were several 
issues in the etching, electroplating and bonding processes.  In our initial prototype 
designs, 50 µm deep microchannels were easily etched by submerging the patterned 
glass slide in hydrofluoric wet etching solution for 28 minutes.  However, the wet 
etching process was slowed down and almost stopped around 88 µm deep after a 50 
minute etching process.  Agitating the etching solution with a stirring bar made the 
bottom of microchannel uneven and often tore the protective Cr / Au layers during the 
glass etching process.  This problem was solved by taking out, washing the device 
carefully with DI water after submerging for 50 minutes, and continuing the etching 
process for additional 20 minutes.   
The patterning of electroplating mold inside the 100 µm deep microfluidic 
channel was one of the major challenges.  If the temperature and time for the soft 
bake cycle were not long enough, the mold structures suffered severe undercut issues 
and often caused problems in the subsequent electroplating process.  Images of the 
undercut photoresist mold structures because of this issue are shown in Figure 3.10.  
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Initially there was post bake process at 120 °C after the second photolithography 
procedures.  However, it turned out that this hard bake process sometimes caused 
deformation in the electroplating molds and subsequent changes in the final 
electroplated ferromagnetic structures.  The post bake process was removed after 




Figure 3.10. Undercut of mold structure due to soft bake issues. Micrograph 




When the electroplating process was carried out, there was huge height 
difference up to 40 µm between ferromagnetic structures and even within one 
structure since the top surface had large curvature.  Two contact points for 
electroplating process were made at each edge of glass slide and power supply line 
was connected to the one of two contact points for specified time, while the other 
contact point was covered and submerged in the electroplating solution.  By 








The first method to cover non-active contact point was by painting the exposed Cu 
area with photoresist, but it required some dry time and it caused peeling off of 
electroplated layers between switching sides.  Later, blue tape for vacuum seal was 
used for quick covering and uncovering of the contact point.  Since the ferromagnetic 
structures required long electroplating times, it sometimes caused overheating of the 
photoresist, by which bubbles were made.  These bubbles made the uneven surface of 
ferromagnetic structures worse (Figure 3.11).  This issue was eased by proper soft 
bake and switching the contact side during electroplating. 
For making inlet and outlet holes at the correct position in top glass slides, a 
CO2 LASER was first used.  However instead of making clean round holes, it gave a 
shattered edge shape or a burnt and melt-down shape.  Thus, a conventional bench top 
drill press machine was used with an SLA-based drilling guide. 
The most severe problems in the fabrication process occurred during the 
glass-to-glass bonding process.  The technique used in the initial bonding process was 
glass fusion bonding, and it requires an exact match in the thermal expansion 
coefficients between the two glass slides.  If there was a slight difference in thermal 
expansion coefficients between the top and bottom glass substrates, those glass 
substrates would be shattered into pieces after the thermal procedures.  In several 
cases, the glass slides after thermal process came out broken because the top glass 
slides were ordered from the manufacturer later than the bottom glass substrates even 




Figure 3.12. Broken devices during glass-to-glass thermal bonding process.  
 
 
 Unlike its predecessors, the six stage cascade system has a much bigger 
chamber and electroplated areas.  This caused deformation in the bottom glass slides 
during the bonding process in many cases, and the top and bottom glass could not be 
completely bonded.  The Curie temperature of Ni81Fe19 alloy powder is 567 °C and 
the thermal bonding process at 685 °C is known to decrease the permeability of 
Ni81Fe19 alloy [89].  As an alternative approach, the top and bottom glasses were 
aligned and bonded using UV curable adhesive resin (Renshape® SL 5510, Vantico 
A&T US, Inc. Lansing, MI, USA) applied between the two glasses by capillary force 
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and cured under a UV lamp for 30 minutes.  UV adhesive bonding process solved 
most of problems associated with the thermal bonding process, but it created other 
problems like occlusion of the microfluidic channel by the introduced UV curable 
adhesive resin as well as open gaps between the top glass and the electroplated 
structures causing some blood cells to pass over the ferromagnetic structures during 




Figure 3.13. Bonding of interface by epoxy type adhesive (left) and UV curable 
adhesive resin (right). 
 
 
The interface bonding process was carried out with epoxy type adhesive, but it 
required more than 2 hours for sufficient bonding and was hard to control.  Later UV 
curable adhesive resin was used for clean and fast bonding between the interface and 
the glass substrates (Figure 3.13). 
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3.5 Experimental Methods 
Human venous blood was collected at the Georgia Tech on-campus health 
center under an Institutional Review Board-approved protocol for blood collection
 
for 
research purposes.  The samples were drawn into evacuated glass tubes containing 
ethylenediamine tetraacetic acid (EDTA) as an anticoagulant.  A 3.0 mM deoxidizing 
isotonic solution was prepared by dissolving sodium hydrosulfite (Sigma-Aldrich Co., 
St. Louis, MO, USA) in a calcium and magnesium free phosphate-buffered saline 
(PBS) solution (Mediatech, Inc., Herndon, VA, USA) at room temperature.  The 
deoxidization and dilution of the blood sample were achieved by adding 500 µL of 
the 3 mM isotonic sodium sulfite solution to 50 µL of whole blood.  SYTO® 13 
fluorescent dye was used to identify the nucleated cells during experiments.  The 
blood sample with SYTO® 13 fluorescent dye was incubated for 2 hours. 
Before introducing the sample, the PMMS system was first treated with 
Pluronic
®
 F108 tri-block copolymer surfactant (BASF Co., Florham Park, NJ, USA) 
solution to reduce the adhesion of blood cells on the channel surfaces.  The surfactant 
solution was used to fill the microfluidic channel and left resident in the chamber for 
5 hours.  After treating the glass surfaces, the substrates were subsequently washed 
three times with PBS solution.  
The fabricated device was mounted onto the center cavity inside the SLA 
alignment jig and permanent magnets were inserted into the side pockets to create an 
external magnetic flux.  Compared to the plastic syringe, a glass syringe gave a more 
regular sample introduction rate at a low volumetric flow rate.  A 500 µL gas tight 
glass syringe (Hamilton Co., Reno, NV, USA) was used to load the incubated blood 
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sample and connect it to capillary tubing through Luertight
TM
 fittings (Upchurch 
Scientific, Inc., Oak Harbor, WA, USA).  Tubing with a thin inner diameter was used 
in an effort to reduce blood sample travel time from the tip of a syringe to the inlet of 
microseparation system, thus minimizing the effect of sedimentation inside the tubing.  
The other end of tubing was connected to the device inlet port through the SLA 
microfluidic interface.  A PHD 2000 syringe pump (Harvard Apparatus, Holliston, 
MA, USA) was used to provide the desired constant volumetric flow rates during the 
separation process. 
  During experiments, the initial volumetric flow rates were set at higher value 
and then lowered to target volumetric flow rates to avoid sedimentation of blood 
samples inside the connecting tubing.  The assembled microsystem was placed under 
a fluorescent microscope and the trajectory of blood cells under a high magnetic 
gradient flux was monitored using the microscope camera and video capture tools 
(Figure 3.14).  The bottom light source was used combined with a UV light source to 
illuminate both fluorescent and non-fluorescent cells with a green light passing filter. 
A total of 2.5 µL of fluid was collected at each outlet port using adjustable 
pipettes (Series 2000, Eppendorf North America Inc., Westbury, NY, USA). The 
separation efficiency of the PMMS system was characterized by counting RBCs in 
the fluid collected at each outlet port using a Coulter cell counter (Multisizer II,, 
Beckman Coulter, Inc., Fullerton, CA, USA).  For cell counting purpose, the 
collected fluid is mixed with 35 mL of buffer solution (ISOTON® II Diluent, 
Beckman Coulter, Inc., Fullerton, CA, USA) in a vial and placed in the cell counter 











3.6 Results and Discussion 
The original interface and package fabricated are shown in Figure 3.15.  The 
original design for microfluidic interface does not have the “[” shaped edge for tip 
holder.  The original package is only equipped a tip holder and several draining holes 
for fabrication.   
 
 




Figure 3.16. Modified microfluidic interface (top) and system package (bottom). 
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The modified microfluidic and system package is shown in Figure 3.16.  The 
removable holding tip was used for easier installation and removal of the 
microseparator chip between experiments.  The holding tip is shown connected to the 
system package.  Two open cavities under the microchannel area were designed to 
provide light passage from the bottom-side microscope light source and two lens pass 




Figure 3.17. The fabricated PMMS system with holding tip. 
 
 
The fabricated six-stage cascade PMMS system is shown in Figure 3.17.  The 
100 µm tall ferromagnetic structures inside the microchannel can be seen.  The 
separation systems were fabricated at the perimeter of glass substrates to minimize 
the distance between the separation channel and the permanent magnets and thus 
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maximize the magnetic field gradient and magnetophoretic force on the untagged 
blood cells.  The inlet holes were placed away from the main channel to give more 
room for microscope lens movement above the separation chamber during 
experiments.  The outlet holes remained open to air to collect the separated blood 
samples with the adjustable pipettes.  A holding tip was used in the removable part of 
the alignment jig to hold the microsystem during experiments.   
Figure 3.18 shows the PMMS system packaged inside the alignment jig with 




Figure 3.18. The assembled PMMS system inside package. 
 
 
 The PMMS system was first tested with prepared blood sample without an 
applied magnetophoretic force acting on blood cells by removing the permanent 
magnets from the package.  At the flow rate of 28.8 uL/hr, 60.4 + 5.25 % of blood 
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cells were collected into the center channel.  The PMMS system was then tested with 
permanent magnets placed in the side pockets.  Figure 3.19 shows images of the RBC 
separation inside the microchannel at an average flow rate of 28.8 µL/hr with an 
applied magnetophoretic force (except right top side picture).  As the blood sample 
traveled the length of the microseparator, the RBC level in the outer channels 




Figure 3.19. Micrographs of the blood cell separation at each stage. 
 
 
 At the output of the central channel in the microseparator, the separation 
efficiency was measured to be 89.5 + 0.20 % for RBCs.  The PMMS system was 
tested at higher volumetric flow rates of 50.4 µL/hr and 72.0 µL/hr.  The measured 
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separation efficiencies were lowered to 86.2 + 1.60 % and 59.9 + 6.06 % respectively.  
As the whole blood travels at a higher flow rate, the residence time of blood cells 
inside the magnetic field gradient decreased, while the drag force by the flow 
increased.  Thus, the chance for RBCs to be captured into the center channel was 
reduced (Figure 3.20).   
 
 
Figure 3.20. Measured separation efficiency of RBCs at each outlet for two 




No clogging from cell coagulation inside the channel was observed during the 
separation.  However, trapped air bubbles in the channel introduced between 
experiments blocked the microchannel and prevented further characterization if not 




CHAPTER 4  
MAGNETOPHORESIS SYSTEM APPLICATION II  
(Cancer Cell Separations) 
 
4.1 Introduction 
Cancer has been one of the largest causes of mortality in the United States 
with the total number of deaths related to cancer increasing annually until recently.  
With the technical advances in cancer early detection technologies and treatments, the 
overall cancer survival rate for patients has been rising.  However, as a primary tumor 
starts to shed cancer cells into the blood stream and those circulating tumor cells 
cause secondary tumors to grow in various sites of cancer patients, clinicians have 
limited options for cancer treatment and the survival rate drops rapidly.  Therefore, 
identifying and determining the malignancy of tumor cells in the early stages of 
cancer progression is very important to deter further metastasis of primary tumors and 
to maximize the success rate in cancer treatments.  The sample size from early 
detected tumors is usually small and manipulating those cells has been a major 
challenge.  The ability to perform the biological experiments efficiently with only a 
small volume of complex fluids makes the microfluidic system a promising candidate 
for point-of-care devices.  Additionally, microfluidic systems offer other practical 
advantages including the potential for operation without the need for an expert 
operator and the potential to be used in resource-limited situations.  
The expression level of specific membrane proteins differs for malignant 
tumor cells and benign tumor cells [90, 91].  For example, during complementary 
 58 
experiments with head/neck cancer cells, it was found that the expression level of the 
protein CD29 was much higher in metastatic head / neck squamous cancer cell lines 
(M4e) than non-metastatic head / neck squamous cancer cell lines (212LN), therefore 
could potentially provide a biomarker for head and neck cancer detection [92, 93].  
Depending on the expression level of CD29, the malignant tumor cells can be 
selectively tagged with magnetic nanoparticles by antigen-antibody reactions (Figure 
4.1).  
The presented continuous flow-based magnetophoresis microsystem will 
enable the separation and collection of a wide variety of cells in small quantity by 













4.2 Microsystem Design 
Initially, the six-stage cascade PMMS system was used to determine the 
feasibility of using the magnetophoretic microfluidic separation system for the 
separation of tagged tumor cells from a complex sample containing a mixture of cells.  
During experimentation, it was confirmed that magnetophoretic microfluidic system 
could separate and isolate targeted magnetically tagged cells successfully.  
Additionally, it was found that several design and operational modifications were 
required due to the much higher magnetophoretic force acting on magnetically tagged 
cells when compared to untagged cells and due to the relatively small percentage of 




Figure 4.2. Operational principle of the multiple stage para-magnetophoresis 
microseparator.   
 
 
 Figure 4.2 illustrates the novel microsystem used to achieve continuous 
separation of magnetically tagged cells from untagged cells.  The operational 
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principle of this microfluidic system is similar to that of the blood cell separator.  
Under a high magnetic field gradient, ‘magnetic’ cells in a mixed cell suspension are 
attracted toward the ferromagnetic capture structures and subsequently forced into the 
center channel while the untagged cells travel along the outer channel.  The remaining 
tagged cells in the outer channel are attracted and separated again at the subsequent 
separation stages.  One major change was made in the design of fluid channel 
network when compared to the RBC / WBC application discussed in Chapter 3.  In 
the separation of RBCs, the cell density of the ‘magnetic’ cells is much higher than 
that of the ‘non-magnetic’ cells.  However, in the separation of tagged tumor cells in 
an application such as CTCs, the cell density of the ‘magnetic’ cells is much lower 
than that of the ‘non-magnetic’ cells.  As seen in Figure 4.2, at each separation point, 
there is ‘V’ shape area so that only ‘magnetic’ cells closely positioned to the edge of 
the ferromagnetic capture structures can be swept into the center channel, while ‘non-
magnetic’ cells remain in the side channels. 
The magnetophoresis system for malignant tumor cell separation requires two 
photolithography steps.  The two mask designs, one for the microfluidic channel and 
one for the ferromagnetic structures are shown in Figure 4.3. 
The design of the tagged cell separation system was similar to the design of 
six-stage cascade PMMS system shown in Chapter 3 for the separation of RBCs from 
nucleated cells.  The distance between the separation chamber and the inlet hole was 
sufficient to provide a better image of the separation chamber area during the 





Figure 4.3. Mask designs for microfluidic channel (top) and electroplated 
ferromagnetic structures (bottom).  
 
 
There were two major design changes from six-stage cascade PMMS system.  
First, the diameter of the two outlet holes was changed from 1.0 mm to 2.0 mm for 
easier collection of the separated cancer cells.  Second, the design of the fluid 
transition region from the outer channels to the diagonal collection channels was 
modified as shown in Figure 4.4.  The change in the design of the transition region 
was necessary because in the separation of tagged tumor cells, the cell density of the 
‘magnetic’ cells is much lower than that of the ‘non-magnetic’ cells, and the 
magnetophoretic force on these tagged cells is much higher than that of the RBCs in a 
 62 
human blood sample.  By changing the design and making a ‘V’ shaped area at each 
separation stage as in Figure 4.4, only ‘magnetic’ cells closely positioned to the edge 
of the ferromagnetic capture structures can be swept into the center channel, while 




Figure 4.4. The design differences between six-stage cascade PMMS system for 





The mask designs were initially drawn and saved in DXF format by 
Autodesk® AutoCAD and sent to an outside vendor for plotting onto transparent film.  
Later, the patterns were transferred from the transparent film to a 4” × 4” chromium-
layered glass mask using a standard photolithography process.  
The microfluidic interface for the tagged cell separator was designed similarly 
to that of the blood cell separator shown in Chapter 3.  Two O-rings were inserted to 
firmly hold the Teflon
TM
 tubing and the “[” shaped space for the tip holder of the 
system packaging to hold the microfluidic system while conducting experiments 




Figure 4.5. Microfluidic interface design. 
 
 
 The system packaging has similar features to that of the blood cell separator 
such as a center stage to place and hold a microfluidic separation system with a 
removable tip and an open cavity under the center stage for light passage.  A major 
change made in the design of system package was the position of the adjustable side 
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pockets for the permanent magnets relative to the separation system.  Each of the side 
pockets can be separated from main package and inserted into several saw-shaped 
locations to change the distance between the permanent magnets and the 
microseparator.  Additional SLA-based columns, which positioned between the 
microseparator and the side pocket, were designed to reduce the magnetic field 
intensity on the microseparator (Figure 4.6). 
   
 




The overall size of the system package platform is 108 mm × 108 mm × 11.5 
mm (length × width × height).  The width of center stage for microsystem was chosen 
to be 22.0 mm and the size of the movable side pocket is 108 mm × 20.5 mm × 15.5 
mm (length × width × height). 
The drilling guide design for correct positioning of the inlet and outlet ports in 
the top glass substrate is shown in Figure 4.7.  For the drawing of the microfluidic 
interface, system packaging, and drilling guide, the Solid Edge® program was used 










4.3 Microsystem Fabrication and Packaging 
The microsystem was composed of microfluidic channels, ferromagnetic 
separation structures, inlet/outlet holes, and microfluidic interfaces.  The overall 
fabrication process of microseparator is similar to that of six stage cascade mode 
blood cell separator and consists of wet etching the glass substrate to create the 
microfluidic channel, electroplating of ferromagnetic separation structures, glass-to-
glass bonding, and bonding of the microfluidic interfaces.    
After the wet etching process, the residual photoresist and metal masking 
layers were removed using acetone, Cr / Au etchant, and piranha cleaning.  The 









Figure 4.9. The microsystem during electroplating process.  
 
 
Sputtered Ti / Cu / Cr layers were used for the electroplating seed layers and 
thick positive photoresist was used for the electroplating molds.  The electroplating 
process was carried out at room temperature with a current density of 10 mA / cm
2
 for 
2.5 hours in the electroplating baths described in Chapter 3 (Figure 4.8 (b)).  The 
thickness of the electroplated permalloy were measured using a P-15 Profilometer 
(KLA-Tencor Corp., Milpitas, CA, USA).  The photoresist layer on the center part of 
a device was removed temporarily for a height reference (Figure 4.9).  Following the 
electroplating process, all the thick photoresist molds and the seed metal layers were 
removed resulting in the 50 µm high ferromagnetic structures inside the microfluidic 
channels.  Photomicrographs of the microseparator at this stage of the fabrication 




Figure 4.10. The microfluidic channel with electroplated ferromagnetic 
structures before bonding process. 
 
 
 The inlet / outlet holes were drilled by 1.0 mm / 2.0 mm diamond drill bits in 
the blank top glass substrate using an SLA fabricated drilling guide.  The drilled top 
glass was aligned and bonded with the microfluidic channel defined bottom glass by 
introducing UV cure adhesive resin between the two glasses using capillary force and 
curing the adhesive under a UV lamp for 30 minutes (Figure 4.8 (c)).  Finally, the 
microfluidic interface was bonded to the microseparator by repeating the UV 
adhesive bonding process (Figure 4.8 (d)).   
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To solve the issue of improper sealing between the top glass and the 
electroplated structures causing unwanted sample flow over the ferromagnetic 
structures during experiments, polydimethylsiloxane (PDMS) bonding was used as an 
alternative approach.  For this bonding method, the ferromagnetic structures were 
over-electroplated for 3 hours to make the edge areas of ferromagnetic structures 
slightly protrude above the etched microfluidic channel.  PDMS in the liquid stage 
was spin-coated on the bottom side (bonding side) of the drilled top glass at 3000 rpm 
for 30 seconds and pre-baked on a hot plate at 50 °C for 20 minutes.  The resulting 
PDMS thickness was measured to be approximately 10 µm, thus adequately 
accommodating the height difference between the surface of the lower glass slide and 
the over-plated electroplated structures.  The pre-baked top glass was aligned 
carefully with the bottom substrate and bonded on a hot plate at 50 °C for additional 2 
hours.  The bonding method using the PDMS layer as sealant layer alleviated the 
issue of sample fluid passing through the unsealed gaps between the top and the 
bottom substrate, but PDMS bonding process was much harder to control than the UV 
curable adhesive bonding process.  Occlusion of the microfluidic channel while using 
the PDMS bonding process was a much larger problem than when using the UV 
curable adhesive.  Figure 4.11 shows the results of the bonding process using PDMS 
as a bonding layer.  The small bubbles on top of electroplated structures show that 
PDMS had successfully sealed the gap between electroplated structures and top glass 
slide, thus preventing fluid flow in this region.  However, as shown in the pictures, 








Finally, a third process was developed to improve the bonding step in the 
fabrication process.  A modified UV curable adhesive bonding process was carried 
out.  By adding a step consisting of applying a small amount of UV curable resin on 
top of the electroplated structures to the previously discussed UV adhesive bonding 
process, the gap between the top glass substrate and the electroplated structures was 
eliminated. 
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4.4 Experimental Methods 
212LN and 686LN-M4e cells were maintained in Dulbecco’s modified 
Eagle’s medium DMEM / F12 medium (1:1) supplemented with 10 % fetal bovine 
serum FBS at 37 °C in a humidified atmosphere with 5 % CO2.  To detach the cells 
from the culture container, all culture media was first aspirated. The remaining 
attached tumor cells were washed with PBS solution once and all PBS solution was 
aspirated.  Cellstripper
TM
 (Mediatech, Inc., Manassas, VA, USA) solution was added 
to culture container and incubated for 10 minutes in an incubator of same condition 
described above.  After incubation, Cellstripper
TM
 solution was removed carefully 
and PBS solution was added.  CD29+ cells were selectively tagged using EasySep® 
(StemCell Technologies, Vancouver, BC, Canada) procedures.  Mouse anti-CD29 
IgG1 antibody (BD 555442, BD, Franklin Lakes, NJ, USA) was used to create IgG1-
tetrameric-antibody complex.  Cells with the CD29 surface marker were then bonded 
with the tetrameric-antibody complex and selectively tagged with magnetic 
nanoparticles.  The tagged cancerous cells were prepared by flowing through the non-
tagged cells in the Easy® magnet.  SYTO-13 fluorescent dye was used to identify the 
tagged cancerous cells from other human blood cells during experiments.  The tagged 
cancerous cell sample with SYTO-13 fluorescent dye was incubated for 2 hour before 
mixed with blood cells.  Human venous blood was collected at the on-campus health 
center under an Institutional Review Board-approved protocol for blood collection
 
for 
research purposes.  The samples were drawn into evacuated glass tubes, containing 
EDTA as an anticoagulant.   
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The magnetophoretic microsystem was similarly treated with surfactant 
solution to decrease cell adhesion on the channel surfaces.  After treating the glass 
surfaces, the substrates were subsequently washed three times with PBS solution.  
The setup for the experiments was similarly prepared as described in Chapter 3.  The 
assembled microsystem and experimental setup is shown in Figure 4.12.  The 
separation efficiency of the microseparator system was characterized by counting the 













4.5 Results and Discussion 
Initially three microseparators with different numbers of separation stages 
were fabricated.  However, after simple separation experiments, a microseparator 
with three separation stages were chosen for further extensive experiments.  Single 









 The fabricated three stage microseparator system is shown in Figure 4.14.  
The 50 µm tall ferromagnetic separation structures inside the microchannel can be 
seen featuring three separation stages.  The UV curable resin could not be introduced 
successfully into the area between two microseparators using capillary force from the 
perimeter edges of the glass substrates.  Two additional holes for UV adhesive resin 
introduction were drilled in top glass.  Inside the microfluidic interfaces bonded to the 
microseparator, a rubber o-ring was inserted for more reliable interconnection.  Two 
side channels #1 and #3 in the microchannel are merged into one side outlet and 











Figure 4.15. The three components of system package (top) and the assembled 
microseparator system (bottom). 
 
 
All three components of system packaging (main platform, two side pockets 
for permanent magnets, and blocking column) are shown in the top figure of Figure 
4.15.  The bottom figure of Figure 4.16 shows the microseparator assembled onto the 
system packaging with permanent magnets in the distant adjustable pockets.  The 
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removable holding tip is used for easier installation and removal of the 
microseparator chip between experiments.  An open cavity in the system packaging 
under the microseparator was used to enable monitoring of the sample cells 
movement during separation by providing light passage from the bottom-side 
microscope light source.  The side pockets were made to adjust the distance between 
the microsystem and the magnets to control the magnitude of magnetophoretic force 




Figure 4.16.  Micrograph of the microsystem with (a) non- tagged cells and (b) 
and tagged cells (Circled). 
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Figure 4.16 shows the microscope images of the tagged and non-tagged cells 
sample inside the microseparator under the para-magnetophoresis.  As expected, the 
tagged cells were forced into the center channel, while non-tagged cells stayed in the 
side channels.  At the flow rate of 100 µL/hr, 71.0 ± 8.37 % of tagged cancerous cells 
were attracted toward center channel, while 78.7 ± 2.53 % of non-tagged cells stayed 
in the side channels.  When the flow rate increased to 200 µL/hr, 71.2 ± 1.38 % of 
tagged cells were attracted toward center channel, while 67.7 ± 4.17 % of non-tagged 
cells stayed in the side channels. 
Separation of cancerous cells from human blood cells was carried out in the 
microseparator with the third stage modified as shown in Figure 4.17.  The 
modification was made to reduce the number of non-tagged cells introduced into the 
center channel.   
The density of blood and cancerous cells for the experiments was 2.5 × 10
7
 
cell/mL and 5 × 10
5
 cells/mL, respectively.  The cancerous cell samples were tagged 
with fluorescent dye to distinguish cancerous cells from the human blood cells.  At 
the flow rate of 100 µL/hr, 20.5 ± 7.95 % of tagged cancerous cells were attracted 
toward center channel, while 93.7 ± 2.45 % of non-tagged cells stayed in the side 
channels.  At 200 µL/hr, 48.9 ± 10.94 % of tagged cells were attracted toward center 
channel, while 97.7 ± 0.81 % of non-tagged cells stayed in the side channels.  
Compared to the original microfluidic channel design, a lesser number of non-tagged 
cells were introduced to the center channel.  However the number of tagged cells 





Figure 4.17.  Micrograph of the microsystem with (a) non- tagged cells (Circled) 
and (b) and tagged cells (Circled) mixed with human blood cells. 
 
 
In separating the target magnetic cells, the two major driving forces are 
magnetophoretic force by the external magnetic source and the drag force by the fluid 
flow.  For the magnetophoresis microsystem to separate target particles continuously, 
the balance between the two forces should be considered carefully.  If the 
magnetophoretic force becomes greater, the required capture time would be reduced, 
but the possibility of target particles being held inside the chamber also increases.  
The balance can be controlled by changing the flow rate, the distance between 
external magnetic source and microseparator, and the magnitude of the external 
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magnetic source.  However, when the introducing sample consists of magnetic cells 
with different level of magnetic susceptibility or different number of tagged magnetic 
beads on the surface, the balance control for the continuous mode separation becomes 




Figure 4.18.  Micrograph of the microsystem with Hold-release Mode Tagged 
Cancer Cells separation from Human Blood Cells. 
 
 
In hold and release mode operation, most of target cells with higher magnetic 
susceptibility are captured during the hold phase and released into capture outlet 
during the release phase by changing the external magnetic source, while a small 
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number of target cells with lower magnetic susceptibility are separated in similar 
fashion with continuous mode operation.  For hold and release mode operation 
(Figure 4.18), the external magnets were positioned closest to the microseparator 
during the sample introduction and removed once all samples were passed through 
the microseparator.   
The introduction of sample were conducted at the flow rate of 100 µL/hr and 
200 µL/hr, 93.3 ± 2.54 % and 71.6 ± 5.27 % of tagged cancerous cells were either 

















CHAPTER 5  




 The phenomenon of translational motion of a neutral body under a non-
uniform field was described as early as 600 B.C. by Thales of Miletus in Turkey who 
observed that when amber was rubbed, it attracted small particles.  Dielectrophoresis 
(DEP) is the translational motion of a neutral matter caused by polarization effects in 
a non-uniform electric field [94].  A charged body moves along the field lines in both 
uniform and non-uniform electric fields, but a neutral body experiences a net force 
only in a non-uniform electric field.  A neutral body stays neutral in an electric field, 
but in a non-uniform electric field the forces on each polarized region are unequal, 
which gives rise to a net force on the neutral particle (Figure 5.1).  By using 
dielectrophoresis, one can remove small particles from suspending media; in 
particular the application of dielectrophoresis for cell manipulation has attracted 














Figure 5.1.  Movement of neutral and charged bodies in a uniform electric field 





A neutral particle suspended in a fluid experiencing a dielectrophoretic force 
can be described as a small dipole under non-uniform electric field.  When a small 
neutral particle with volume v  is placed in a static external electric field eE
r
 at 
equilibrium, the net force F
r
 due to an applied field is given by:  
eEF
rrr
)( ∇•= µ    (5.1) 
where µ
r
 is the dipole moment vector of the particle.   
When a particle is isotropically, linearly, and homogeneously polarizable, the 
dipole moment µ
r
can be expressed as eEv
rr
αµ = , where α  is the tensor polarizability 
or dipole moment per unit volume in unit field, then Equation 5.1 becomes 
ee EEvF
rrr
)( ∇•= α   (5.2) 
Since the electric field is an non-rotational or a conservative field, by using the vector 
transformation )()()()()( ABBAABBABA
rrrrrrrrrr
×∇×−×∇×−∇•−•∇=∇• , Equation 











∇•−∇=∇•  from the vector transformation [94]. 
The effective dipole moment eµ
r
 of a spherical particle embedded in a dielectric 










== , where a  is radius of particle and the excess 
polarization eP
r
 can be expressed as iOe EKKP
rr
ε)( 12 −= , where Oε  is permittivity of 
free space, iE
r
 is internal electric field in the sphere in the direction of the external 
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field, and 21 , KK  are the relative dielectric constant of the medium and particle, 
respectively. 
If the dielectric sphere is placed at the origin and subjected to a uniform z-directed 
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With the given boundary conditions, iE
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Equation 5.5 is based on the assumption of ideal or perfect dielectrics having zero 
conductivity.  However, in the case of real dielectrophoresis, especially for cell 
manipulation, both the medium and the neutral particle are conductive and polarizable.  





εωε j−=)(* , where σ  is electrical conductivity and ω  is the angular 
frequency of the external field.  Under a time dependent external electric field, the 
time-averaged dielectrophoretic force is:  
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=CMf  (5.6) 
CMf  is the Clausius-Mossotti factor and rmsE  is the root mean square value of the 
external electric field [96].   
From Equation 5.6, the response of cells or particles suspended in a liquid 
medium in a non-uniform electric field because of an the applied AC source is 
strongly dependent on the frequency of the applied field and the conductivity of the 
fluid medium.  Depending on their complex dielectric constant, some cells experience 
attractive forces in the electric field gradient and others experience repulsive forces 
(under the same frequency of the applied field and the conductivity of suspending 
medium condition).  Most cells experience a positive DEP force in the high frequency 
range and a negative DEP force in the low frequency region. At the crossover 
frequency, or transition frequency, no DEP forces are exercised on the cells.  The 
frequency response of each type of cell is dependent on various cell characteristics, 
such as the membrane characteristic, the internal structure, and the cell size variation.   
The major advantage of DEP compared to other separation schemes is that the 
variability in the frequency response of cells is selective enough for DEP 
microsystems to differentiate between similar cell types.  Also, DEP is more 
advantageous in that it does not require any labeling of cells.  Microfluidic systems 
using DEP have been shown to manipulate biological cells successfully using 
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intrinsic dielectric affinity differentiation and have demonstrated highly selective 
isolation of target rare cells from the mixture of various blood cells without any 
tagging. 
 
5.3 Capture and Release Mode DEP Microsystem for Cell Separation 
In early microfluidic separation systems using dielectrophoresis, separation of 
cells was carried out in discontinuous mode, or capture and release mode [96~99].   
 
 
Figure 5.2.  Separation of MDA231 human metastatic breast cancer cells (larger 
cells) from dilute peripheral blood. (A) During initial sample introduction (B) 
During blood cell release (C) Cancer cells captured on the electrode tips while 
blood cells had been swept downstream. (D) electrode close to outlet where only 




First cell mixtures with different dielectric properties are introduced into a chamber 
with closely positioned but separated electrodes.  An AC electrical signal creating 
non-uniform electric field between electrodes is applied at a frequency at which only 
target cells experience strong attractive DEP force so that non target cells are swept 
downstream with elute flow while target cells are captured at the tip of the electrodes.  
Once non target cells are swept into the outlets, the target cells are released with the 
elute flow by turning off the electrical field. 
Becker et al successfully separated MDA231 breast cancer cells from T 
lymphocytes and erythrocytes in an isotonic solution consisting of 8.5 % sucrose plus 
0.3 % dextrose buffer, with a DEP microfluidic system (Figure 5.2).   
In the late 1960s, J. S. Crane and H. A. Pohl showed that live and dead yeast 
cells show different dielectrophoretic reactions [99] and Markx et al have 
demonstrated separation of viable and non-viable yeast cells successfully with a 
microfluidic system [100].  Tai et al presented an automatic DEP separation systems 
consisting of several microfluidic valves and pumps (Figure 5.3) 
 
 
Figure 5.3.  Schematic illustration of an automatic cell/nucleus separation and 
collection chip with a microchannel, an S-shape micropump, four microvalves 
and a DEP microelectrode array. (Image from [101]). 
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5.4 Continuous Mode DEP Microsystem for Cell Separation 
Early DEP microsystems required several discontinuous steps of retaining, 
washing and, then releasing particles of interest.  Unfortunately, the automation of 
these steps complicated the overall microfluidic system design.  Also, the use of 
discontinuous separation systems is limited in high throughput applications because 
of their discontinuous nature.  Continuous mode DEP separation can increase the 
throughput.  Continuous mode DEP systems should have several outlets and the 
electrodes are positioned to guide different types of cells into different outlets. 
 
 
Figure 5.4. Device concept and architecture of continuous separation system 
using isodielectric methods. (Image from [102]). 
 
 
Recently, several continuous mode DEP microseparators were developed.  M. 
D. Vahey and J. Voldman have demonstrated continuous separation of nonviable 
yeast cells from viable ones based on equilibrium methods [102].  The method used 
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in their device was isodielectric separation which is analogous to isoelectric focusing.  
Isoelectric focusing is a method in separating particles based on their electric charge 
differences.  For example, a protein placed in a medium where the pH of its 
surrounding is below its isoelectric point will be positively charged and move toward 
the cathode.  If there is a pH gradient in the medium, the protein will pass through a 
gradient of increasing pH and stop at the position where its isoelectric point matches 
the pH of its surrounding.  Instead of using a pH gradient with electrophoresis, they 
separated cells in an electrical conductivity gradient using dielectrophoresis.   
 
 
Figure 5.5. Device architecture of two stage DEP cell sorter using the difference 
in the magnitude of negative DEP forces. (Image from [103]). 
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Pommer et al reported separation of platelets from diluted whole blood [103].  Unlike 
other DEP separation system using positive DEP force as the guiding force, they 
utilized the differences in the magnitude of negative DEP forces. 
Li et al employed electrode array structures biased by an on-chip resistive ladder 
network to control individual electrode voltages in creating non-uniform ‘isomotive’ 
fields.  By using non-uniform isomotive DEP fields, positive and negative DEP 
particles were pushed into different region and separated [104].   
However, the capability of continuous separation in most of microsystems has 





Figure 5.6. DEP microfluidic separator using non-uniform ‘isomotive’ forces 
created by electrode array structures biased by an on-chip resistive ladder 
network. (Image from [104]). 
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5.5 Applications of Microscale Dielectrophoresis System 
Two dielectrophoretic microsystems were developed and characterized in this 
work.  The first dielectrophoretic microsystem was developed to determine the 
crossover frequency of different cell types.  The second dielectrophoretic 
microseparator with two inlets for sample stream and sheath flow and two outlets for 
target cells and non-target cells was developed for high throughput continuous blood 
cell manipulation.  The development and characterization of both dielectrophoretic 

















CHAPTER 6  
 DIELECTROPHORESIS SYSTEM APPLICATION I  
(Blood Cell Separation) 
 
6.1 Introduction 
The response of biological cells or particles suspended in liquid media 
exposed to a non-uniform electric field is strongly dependent on the frequency of the 
applied field and the conductivity of the fluid medium.  Also, the frequency response 
of each type of cell is dependent on various cell characteristics, such as the membrane 
characteristic, internal structure, and cell size variation.  The resulting variability in 
the frequency response of different cells is selective enough for DEP microsystems to 
differentiate between similar cell types.  Becker et al [98] have shown that in the 
isotonic solution of 8.5 % sucrose plus 0.3 % dextrose buffer, the crossover 
frequencies for MDA231 breast cancer cells, T lymphocytes, and erythrocytes are 15, 
58, and 95 kHz, respectively.  I. Doh and Y. H. Cho have shown the different DEP 
response of viable and non-viable yeast cells in terms of the medium conductivity and 
applied electric field frequency [105].  Also, DEP is more advantageous in that it does 
not require any labeling of cells in separating different type of cells.     
In Chapter 3 and Chapter 4, blood and cancer cell separators using 
magnetophoresis were presented.  Even though the presented magnetophoretic 
separation systems have shown high separation efficiency with considerably high 
volumetric flow rate for RBCs, separation of cancerous tumor cells from non-
magnetic cells in human blood requires additional downstream separation apparatus.  
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With its highly selective and non-invasive nature, a DEP system was chosen as the 
downstream separation system for further sub-classification of different cell types.  
In the following sections, the design and fabrication of a continuous flow 
dielectrophoretic microsystem capable of switching the input cell stream and 
separation of different cell types in a suspending medium are presented.  With the 
switching capability, the microsystem can be used to extract cell free media from 
whole blood samples.  Quantitative measurements of switching efficiencies of blood 
cells using a continuous flow DEP system are reported.  Experimental results of DEP 
switching using human whole blood are discussed along with the separation of 
different cell types in human whole blood.   
The significance of this research is the development of a microsystem for 
high-throughput continuous separation/manipulation of blood cells achieved with 
comb-type electrodes angled away from the laminar flow direction.  In order to 
manipulate biological cells more efficiently, the DEP system utilizes induced hopping 
movement of blood cells between neighboring electrodes depending on their 
dielectric properties.   
 
6.2 Microsystem Design 
A conceptual view of the implemented continuous flow dielectrophoretic 
microsystem is shown in Figure 6.1 (a).  Overall, the microsystem consists of two 
inlets, two outlets, and one separation chamber having comb-shaped electrodes.  The 
sample is introduced into the device through the center inlet.  The fluid is focused by 
two sided sheath flow (buffer #1, #2) and travels in a laminar flow.   The DEP forces 
 94 
are created by the downstream comb-type angled electrodes and the various types of 
cells in the fluid will move differently according to their native dielectrophoretic 
characteristics.  The electrodes are centered on the input sample channel and the 
outlet #1 channel with decreasing comb tooth length from the input to the output of 
the microseparator along the length of the DEP chamber.  This guides the target cells 








The cell streams during continuous flow operation of the dielectrophoretic 
microsystem are depicted with the red and blue arrows in Figure 6.1 (a).  Without any 
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force acting on the cells, all cells in the microfluidic channel introduced through the 
sample inlet, travel with laminar flow and are collected into outlet #2 (blue-line).  
Under a high gradient electric field created by the alternating electrodes, the cells that 
experience positive DEP force are attracted toward the electrode edges; thus the cell 
stream is deflected toward outlet #1 (red-line), while the cells experiencing negative 
DEP force are levitated above the surface and swept with laminar flow to outlet #2 
(blue-line).   
To separate out the cells more efficiently using positive DEP force, the DEP 
system utilizes the induced hopping movement of the blood cells between 
neighboring electrodes by adjusting the release phase and attraction phase properly.  
Individual cell movement during one hopping period is described in Figure 6.1 (b). 
The DEP microsystem for blood cell separation requires two photolithography 
steps.  Two mask designs for the microfluidic channels and comb-shaped electrodes 
are shown in Figure 6.2.  In the design of the microfluidic channel, there were 
additional ditches surrounding the inlet and the outlet microfluidic channel and 
separation chamber to protect them during the bonding process.  The mask designs 
were initially drawn and saved in DXF format by Autodesk® AutoCAD and sent to 
an outside vendor for plotting services on transparent film.  Later, mask patterns were 
transferred from the transparent film to a 4” × 4” chromium-layered glass mask using 













Figure 6.2. Mask design for microfluidic channels (top), original comb-shaped 





The microfluidic interface for the DEP microsystem was designed similarly to 
those of the magnetophoretic cell separators.  The major difference is that it has two 
inlet ports for sheath buffer flow and sample input.  Each port has two O-rings 
inserted to firmly hold a tubing and a “[” shaped edge to give spaces for the system 
package tip holder that holds the microfluidic system while conducting experiments.  
Since the overall size of the interface is larger than previously developed interfaces, 
there are two additional deep “[” shaped edge for the introduction of UV curable 




Figure 6.3. Microfluidic interface design. 
 
The dielectrophoresis system packaging is composed of one center stage to 
place and hold the assembled microsystem and ten accessing holes for electrical wire.  
The system packaging design is shown in Figure 6.4.  
Similar to the other system packages described in Chapter 4 and Chapter 5, it 
has open cavities under the microchannel to enable monitoring of the blood cell 
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movement during experiments by providing light passage from the bottom-side 
microscope light source.  The overall size of the system packaging is 103 mm × 35.0 
mm × 9.5 mm (length × width × height).  The width of center stage for microsystem 




Figure 6.4. Microfluidic interface and system packaging design. 
 
 
The drilling guide design for correct positioning of the inlet and outlet ports in 
the top glass substrate is shown in Figure 6.5.  For the drawing of the microfluidic 
interface and system packaging, Solid Edge® program was used and the design was 








6.3 Microsystem Fabrication and Packaging 
The continuous flow DEP microsystem consists of a glass microchannel, angled 
comb-shape planar electrodes, microfluidic interface, and system packaging.  The 
overall fabrication process for the microchannel is similar to those of 
magnetophoretic microsystems.   
Cr / Au layers were used as protective coatings during the hydrofluoric acid wet 
etching process as previously described in Chapter 3.  The 50 µm deep microfluidic 
channels were realized by hydrofluoric wet etching of glass for 30 minutes (Figure 
6.6 (a)).  After wet etching, the residual photoresist and metal masking layers were 
removed using acetone, Cr / Au etchant, and piranha cleaning.  The 500 Å / 2500 Å 
thick Cr / Au layers for electrodes were sputtered with the DC sputterer on the front-
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side surface of the etched glass substrate.  Thick negative photoresist was spin-coated 
on the etched side of the glass substrate and soft baked in a vacuum oven at 120 ºC 
for 30 minutes.  The downstream comb-type angled electrodes were defined through 
UV light exposure using the Karl Suss MA-6 Mask Aligner, and the photoresist was 
developed in photoresist developer.  Exposed Cr / Au layers were etched away and 




Figure 6.6.  The fabrication process of the DEP microseparator. 
 
 
The inlet holes were drilled by a 1.0 mm diameter diamond drill bit and the 
outlet holes along with the electrode connections / test holes were drilled by a 2.0 mm 
diameter diamond drill bit.  A fixture fabricated using SLA was used for drill bit 
positioning.  The drilled top glass was aligned and bonded with the microfluidic-
channel-defined bottom glass by using UV curable adhesive resin.  Capillary force 
was used to draw the resin between the two glass slides, and they were then cured 
under a UV lamp for 30 minutes (Figure 6.6 ©).  The SLA-based microfluidic 
interface was bonded to the microseparator by repeating the UV adhesive bonding 
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process (Figure 6.6 (d)).  Finally, two electric wires were connected to each electrode 
pad through the electrode connection holes using conductive silver paste.   
There were two major issues in the fabrication process of the DEP 
microsystem; disconnected electrodes and trouble with bonding between the two 
glass slides.  In the original electrodes layout shown in Figure 6.2, all comb-shape 
electrodes were connected to each contact pad through a narrow line.  Since those 
electrodes were sputtered on the etched bottom glass, electrical disconnection often 









 Moreover, as shown in the top figure of Figure 6.7, the width of the 
connecting wire between each comb-shape electrode was similar to that of each 
electrode and this increased the resistance between the contact pad and the electrode, 
especially for those positioned far away from the contact pad.  Therefore the DEP 








To fix the above-mentioned problems, the electrode layout was modified such 
that all comb-shape electrodes were connected to the contact pad through a large area 
wire as shown in the bottom figure of Figure 6.7.  The UV adhesive bonding process 
provided clean and firm bonding between the two glass slides, but as mentioned in 
Chapter 3, the microfluidic channel was often blocked and the shape of the separation 
chamber was distorted by the UV curable adhesive.  To address this issue, additional 
ditches were etched surrounding the inlet and the outlet microfluidic channel and 
separation chamber as shown in Figure 6.8. 
 
 
6.4 Experimental Methods 
Human venous blood was collected into evacuated glass tubes, containing 
EDTA as an anticoagulant.  A solution of 8.5 % (w/v) sucrose plus 0.3 % (w/v) 
dextrose buffer was used to dilute the human whole blood sample to a ratio of 10:1, 
thus lowering the suspending media conductivity.  SYTO-13 fluorescent dye was 
used to identify the nucleated cells during the experiments.  The diluted blood sample 
with SYTO-13 fluorescent dye was incubated at 37 °C for 2 hours. 
Before introducing the sample, the microseparator was treated similarly with 
Pluronic
®
 F108 tri-block copolymer surfactant solution to reduce the adhesion of 
blood cells on the channel surface during the experiments.  The microsystem was 
assembled into the SLA system packaging and the attached electric wires were 
connected to the output of a 33250A Function / Arbitrary Waveform Generator 
(Agilent Technologies, Inc., Santa Clara, CA, USA).   A function generator capable of 
providing burst mode AC signal can create the periodic dielectrophoretic force in the 
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DEP microsystem that enables the cells experiencing the positive DEP force to hop 
between adjacent electrodes.  A 500 µL gas tight glass syringe (Hamilton Co., Reno, 
NV, USA) and a 3 mL luer lock syringe were used to load the incubated blood sample 
and the buffer solution.  The syringes were connected to capillary tubing through a 
Luertight
TM
 Fitting (Upchurch Scientific, Inc., Oak Harbor, WA, USA).  The opposite 
ends of the capillary tubing were connected to the two inlet ports on the DEP 
microseparator through the SLA fabricated microfluidic interconnects.  A PHD 2000 
syringe pump (Harvard Apparatus, Holliston, MA, USA) was used to provide the 











The assembled microseparator was placed under a fluorescent microscope and 
the trajectory of blood cells was monitored and recorded using the microscope camera 
and video capture tools (Figure 6.9).  The switching efficiency of the 
dielectrophoretic separation system was characterized by counting the number of the 
RBCs from each outlet port using a Coulter Cell Counter (Multisizer II, Beckman 
Coulter, Inc., Fullerton, CA).  The separation efficiency was measured by counting 
the number of the WBCs from each outlet port using video imaging capture tools. 
 
6.5 Results and Discussion 
Initially various DEP microsystem designs were proposed and fabricated 
including 3D electrode design as shown in the top figure of Figure 6.10.  However, 
because of several fabrication constraints, this 3D electrodes design was discarded 
and the microseparator with two inlets and two outlets was chosen for further 
experiments.  The initial electrode layout is shown in the bottom figure of Figure 6.10.   
The fabricated microsystem is shown in Figure 6.11.  Three input channels 
and comb-type angled electrodes which are centered on the input sample channel and 
the outlet #1 channel are shown.  An additional narrow microchannel was etched 
around the main separation channel to prevent UV adhesive resin from flooding into 
the main channel during the UV bonding process. 




Figure 6.10. 3D electrode design (top) and DEP microseparator with original 
electrode layout (bottom). 
 
 
The microfluidic interface with two interconnection ports is shown bonded to 
the microseparator in the bottom figure of Figure 6.11.  Two electrode connections / 
test holes on each electrode were drilled to test the electrical connections after the 
conductive wires were bonded using silver paste.  Successful electrical connection 
was verified by measuring the resistance between one of the conductive wire ends 
bonded to the connection hole and the exposed Cr / Au layers in the electrode test 





Figure 6.11.  The fabricated DEP microsystem. 
 
 
The microsystem was tested for the response of different blood cell types to the 
DEP force.  Based on the results of the different blood cell responses, the experiments 
to switch the blood cell stream and separate different blood cell types were carried out. 
Figure 6.12 shows the continuous flow dielectrophoretic separation system 
packaged inside the system packaging with electrical connections attached to the 
electrode pads.  The system packaging for dielectrophoresis is composed of one 
center stage to hold the dielectrophoretic separation system, several small square 
holes for electrical wire connections, and one long rectangular cavity under the 
microchannel area to enable monitoring of blood cell movement during the 
experiments by providing light from the bottom-side microscope light source.  The 
removable holding tip was used for easier installation and removal of the 




Figure 6.12. The Assembled DEP microsystem. 
 
 
The DEP response of each blood cell type was monitored to find the transition 
frequencies while letting the blood sample flow at 5.0 µL/hr to reduce the 
sedimentation without the sheath flow.  The transition frequency for WBCs was 
found to be around 500 kHz.  The crossover frequency for RBCs was hard to 
determine because of the proximity between each cell.  The density of RBCs was 5.0 
× 10
8
 cells/mL and when RBCs experienced positive DEP forces, they tended to 
make a chain, which demonstrated a much lower transition frequency than single 
RBC.  Some RBCs start to show a positive DEP reaction as low as 260 kHz, while 
most RBCs showed a positive DEP response above 600 kHz.  The transition 
frequencies of both blood cell types showed dependency on the conductivity of the 
buffer used for focusing sheath flow.  When the original buffer solution was used as 
sheath flow buffer, the overall transition frequency was lowered to 150 kHz.  The 
blood sample flow from the inlet port became focused into one stream by the side 
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sheath flow and stayed focused throughout the length of the separation channel.  





Figure 6.13.  The micrographs of blood cells at the entrance, middle and exit of 
the channel during switching mode operation. 
 
 
Without an applied DEP separation force, 99.21 ± 0.08 % of the cells from the 
input sample traveled in the laminar flow direction and were collected into outlet #2.  
A 2.0 MHz, 8 Vp-p AC signal was supplied in burst mode (0.2 second ON and 1.3 
second OFF) to create the hopping movement of the blood cells between adjacent 
electrodes.  Figure 6.13 (b) shows switching of the input blood cell stream from outlet 
#2 to outlet #1 under positive DEP force.  For the switching operation, 96.16 ± 
2.48 % of the cells were deflected from the original flow direction and collected into 
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outlet #1.  The volumetric flow rate for this experiment was 20.0 µL/hr (3.0 × 10
3
 
cells/sec).  The periodicity of the burst mode (periods for release and attraction phase) 
used for the switching operation was chosen based on the time for the cells to cross 
one or two electrodes during one period.  The switching efficiency of the 
dielectrophoretic microseparator was characterized by counting the number of cells in 
2.5 µL of the fluid collected at each outlet port using a Coulter Cell Counter 
(Multisizer II, Beckman Coulter, Inc., Fullerton, CA).   
The WBCs separation from RBCs experiments were conducted using modified 
sheath flow buffer.  The modified buffer solution consisted of 10 parts of original 
buffer solution and 1 part of a calcium and magnesium free PBS solution (Mediatech, 
Inc., Manassas, VA, USA).  A 3 MHz, 8 Vp-p AC signal was supplied in burst mode 
(0.33 second ON and 1.17 second OFF) to perform the separation of WBCs from the 
whole blood sample.  The volumetric flow rate of the blood sample was 10.0 µL/hr 
(1.5 × 10
3
 cells/sec).  Using the stated experimental condition, the RBCs did not 
experience a positive DEP force and traveled in the laminar flow direction and were 
collected into outlet #2.  The WBCs demonstrated positive DEP attraction to the 
electrode edges and moved toward outlet #1.  Figure 6.14 shows images of the cell 
separation in the microsystem.  The separation efficiency was measured by counting 
the fluorescent WBCs passing through each outlet.  59.39 ± 4.24 % of the WBCs 
were deflected from the original flow direction and collected into outlet #1, while all 








 The microsystem has successfully demonstrated the ability to switch the 
whole blood stream with high efficiency by using focusing sheath flow and  positive 
DEP force.  The separation of WBCs from RBCs was also demonstrated.  The 
separation was not as efficient as in switching operation, but all RBCs were collected 
in outlet #2, thus outlet #1 only contained WBCs.  If all the WBCs deflected from 
main sample stream were considered as separated WBCs, the efficiency is 74.79 ± 
4.21 %. 
During the experiments with the DEP microseparation system, it was 
observed that some WBCs adhered to the sputtered gold electrodes until they 
experienced a strong negative DEP force.  Gold is generally known as a bio-
compatible material, but when the WBCs encounter the small step in electrodes edges, 
it may trigger adhesion of WBCs to the surface of the electrode edge.  No clogging 
from cell coagulation inside the channel was observed during the separation.  
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However, trapped air bubbles in the channel that were introduced between 
experiments blocked the microchannel and distorted the cell stream flow if not 
removed before the switching or separation process. 
The continuous flow dielectrophoretic microseparation system has 
successfully demonstrated the ability to switch blood cell streams in laminar flow, 
based on the native dielectrophoretic properties of the cells without the need for 
tagging or chemical modification of the blood sample.  With the high efficiency 
switching capability, the microsystem can be used to extract cell free media from 
whole blood samples.  The separation capability of the presented microsystem was 
not as high as the switching capability, but the unique design and operation principle 
of microsystem enabled the collection of pure target cells in the collection outlet in 
continuous fashion, and there are many applications that could benefit from such a 












CHAPTER 7  
DIELECTROPHORESIS SYSTEM APPLICATION II  
(Cancer Cell Separation and Characterization) 
 
7.1 Introduction 
In Chapter 3, the removal of RBCs from a human whole blood sample using 
magnetophoresis was presented.  While the presented magnetophoretic separation 
system has successfully separated RBCs in a blood sample with high separation 
efficiency at considerable volumetric flow rates, to further sub-categorize different 
cell types, additional downstream separation system is required.  The frequency 
response of each type of biological cell under dielectrophoresis is dependent on 
various cell characteristics.  This variable frequency response enables a DEP 
microsystem to differentiate successfully between similar cell types.  Also, a DEP 
separation system is advantageous in that it does not require any labeling of cells in 
order to separate different cell types.  Therefore, dielectrophoresis was chosen as a 
downstream separation scheme for cancer cell separation.  In Chapter 6, the 
development of a continuous flow dielectrophoretic system for blood cells was 
presented.  The dielectrophoretic microsystem has successfully switched blood cell 
streams between two outlets and separated WBCs from other blood cell types.  
During the separation of WBCs, it was found that even though the crossover 
frequencies of RBCs and WBCs were quite close. Manipulating the conductivity of 
the solution of the sheath flow buffer, changes the conductivity of the sample solution, 
allowing successful separation.  
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In the following sections, qualitative measurement of crossover frequencies 
for different cell types suspended in various buffer solutions will be presented with 
brief description of the design and fabrication of a dielectrophoretic microsystem 
capable of measuring the crossover frequencies of different cell types.  Also, 
quantitative measurements of separation efficiencies of head / neck cancer cells from 
blood cells are reported using the previously developed DEP microsystem.   
 
7.2 Microsystem Design 
The overall design of the dielectrophoretic microsystem used to measure the 
crossover frequencies of various cell types suspended in buffer solutions with 
different conductivities is similar to that of the previously described DEP 
microsystem in Chapter 6.  The difference from the previously described DEP 
microsystem is that the microsystem does not have a sheath flow inlet for focusing 
the sample cell stream because it does not need the high-throughput separation 
capability in continuous mode operation.  The microsystem consists of a single inlet, 
three outlets, and one measurement chamber with comb-shaped electrodes.  The DEP 
forces are created between the comb-shaped electrodes and the cells in the sample are 
exposed to the DEP force while flowing at the specified flow rate.  By monitoring the 
motion of the cells under the DEP force in different suspending buffer solutions, the 
crossover frequencies of different cell types were measured.   
For fabrication, the DEP microsystem requires two photolithography steps.  
The mask layouts for the microfluidic channel and comb-shaped electrodes are shown 





Figure 7.1. Mask design for microfluidic channel (top) and comb-shaped 
electrodes (bottom).  
 
 
For the previously described DEP microseparator to separate different cell 
types continuously, the fluid in the DEP chamber should move in a laminar flow.  
When there was an undesired bump on the wall of a separation chamber or an air-
bubble in a microchannel, the shape of the fluid flow became distorted and the DEP 
microsystem could not separate cells effectively.  Additional ditches were placed 
surrounding the microfluidic structures to protect them from distortion in shape 
resulting from infiltrated UV curable adhesive during the bonding process.  Since the 
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new DEP microsystem does not need to perform a continuous flow separation, the 
additional ditches surrounding the inlet / outlet microfluidic channels and the 
separation chamber were removed from the design.   
The mask designs were drawn with Autodesk® AutoCAD and saved in DXF 
format.  The file was sent to an outside vendor for plotting on a transparent film.  
Later, mask patterns were transferred from the transparent film to a 4” × 4” 




Figure 7.2. Microfluidic interface design. 
 
 
The microfluidic interface of this DEP system was designed similarly to that 
of previously presented ones.  It has two O-rings inserted to hold a tubing firmly and 
“[” shaped edge to allow space for the system packaging tip holder to secure the 
microfluidic system while conducting experiments (Figure 7.2).  The system 
packaging design was unchanged from that of DEP blood cell separator presented in 
Chapter 6. 
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The drilling guide design for correct positioning of the inlet / outlet ports and 
electric connection / test holes in the top glass substrate is shown in Figure 7.3.  The 


















7.3 Microsystem Fabrication and Packaging 
The DEP microsystem consisted of a glass microchannel, comb-shape planar 
electrodes, microfluidic interfaces and system packaging.  The overall fabrication 
processes for the microchannels are almost identical to those of the dielectrophoretic 








The 50 µm deep microfluidic channels were patterned and etched into a glass slide by 
hydrofluoric acid wet etching with photoresist and Cr / Au protective layers.  Pictures 




Figure 7.5.  The channel etched device. 
 
 
Once the glass etching process was completed, the residual photoresist and Cr 
/ Au layers were removed (Figure 7.4(a)).  New Cr / Au electrodes layers were 
sputtered using a DC sputterer and patterned with another photolithography step 
(Figure 7.4(b)).  The inlet / outlet and electrical connection holes were drilled by 
using an SLA-based drilling guide on a new glass slide and glass-to-glass bonding 
between two glass slides was performed to enclose the microfluidic channel area 
using UV curable resin (Figure 7.4(c)).  The microfluidic interface was fabricated by 
an SLA process.  In the previous DEP microsystem described in Chapter 6, the sheath 
flow introduction channels encircled the sample inlet.  This made a bonding process 
more difficult since UV curable adhesive should be introduced separately and 
carefully in the encircled area.  Even with the additional ditch structures protecting 
the microchannels, the encircled area was so tiny in size that the separate introduction 
of UV curable adhesive often led to bonding failures. By removing the sheath flow 
introduction channels, which encircle the sample inlet, the bonding process using UV 
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curable adhesive resin became much simpler and the additional narrow ditch around 
the main separation channel was not needed for successful bonding.  A glass-to-
plastic bonding process was carried out in a similar fashion to that of glass-to-glass 
bonding (Figure 7.4(d)).   
Finally, wires were connected to the contact pads on the glass chip through the 
electric connection holes with silver paste (CW2200 MTP CircuitWorks® 
Conductive Pen, ITW Chemtronics®, Kennesaw, GA, USA).  The electrical 
resistance between the wire end and an electric connection test hole was measured to 











7.4 Experimental Methods 
A solution of 8.5 % (w/v) sucrose plus 0.3 % (w/v) dextrose buffer and a 
calcium and magnesium free PBS solution were used to create four suspension media 
(Buffer #1 ~ #4) with different conductivities.  Buffer #1 consisted of a solution of 
8.5 % (w/v) sucrose plus 0.3 % (w/v) dextrose buffer.  Buffer #2 consisted of 97.5 
parts buffer #1 and 2.5 parts PBS solution.  Buffer #3 was made from 5 % by volume 
PBS mixed with buffer #1 with PBS solution contributing 5 % of Buffer #3.  Buffer 
#4 was mixed using 92.5 % by volume buffer #1 plus 7.5 % by volume PBS.  Human 
venous blood was collected into evacuated glass tubes, containing ethylenediamine 
tetraacetic acid as an anticoagulant and re-suspended into the prepared buffer 
solutions. 
The procedures for the head / neck cancer cell culture and preparation are 
similar to those described in Chapter 4.  In this case, only 212LN cancer cells were 
used as a cancer cell sample.  The cancer cells were cultured in DMEM / F12 medium 
(1:1) supplemented with 10 % FBS at 37 °C in a humidified atmosphere with 5 % 
CO2.  The cells were detached from culture container with Cellstripper
TM
 solution 
following wash / aspiration / incubation procedures.  The cancer cells were collected 
by centrifugation and re-suspended in the four different buffer solutions.  Later, the 
detached cancer cells were filtered through a cell strainer with a 20 µm mesh size to 
ensure that only isolated cancer cells were present in the sample fluid. 
Before introducing a sample, the DEP microsystem was treated with 
surfactant solution to decrease cell adhesion on the microchannel surfaces.  The 
microsystem was subsequently washed three times with PBS in a similar fashion as 
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previous experiments.  The overall setup for the experiments was identical to that in 
Chapter 6.  The microsystem was assembled with the system packaging, and the 
electric wires were connected to the output of a function generator.  A 500 uL gas 
tight glass syringe was used to load the prepared cell sample and connect it to 
capillary tubing through a Luertight
TM
 Fitting while the opposite end of the capillary 
tubing was connected to the inlet port on the DEP microseparator through the SLA 
fabricated microfluidic interface.  A syringe pump was used to provide a constant 
volumetric flow at low flow rates.  
 
7.5 Results and Discussion 
The fabricated microsystem has one inlet, three outlets, and one measurement 
chamber with comb-shaped electrodes.  Two electric connection wire and two electric 
connection test holes are also shown in Figure 7.7.  The fabricated microsystem is 
shown in Figure 7.7. 
The DEP response of RBCs and cancer cells in different suspending solution 
were monitored to find the transition frequencies under the microscope.  In buffer #1, 
cancer cells started to show positive DEP reaction at frequencies as low as 50 kHz 
and most cells were strongly attracted toward the positive DEP region above 150 kHz, 
while the positive reaction of RBCs started around 150 kHz and became obvious 
above 250 kHz.  With buffer #2, positive DEP reaction of cancer cells initiated 
around 120 kHz and most cells clearly showed positive reaction above 250 kHz, 
while the RBCs’ DEP reaction started around 250 kHz and became clear above 350 




Figure 7.7.  The fabricated DEP microsystem. 
 
 
In buffer #3, cancer cells showed positive DEP reactions beginning around 140 kHz, 
but most cells were attracted around the dense electrical field area only above 600 
kHz.  The positive reaction of RBCs in buffer #3 began around 400 kHz and became 
obvious above 500 kHz.  With buffer #4, positive reaction of cancer cells began 
around 210 kHz, but the reaction was weaker compared to those in different buffers at 
even higher frequencies.  The RBCs in buffer #4 started to show weak positive DEP 
reactions above 500 kHz range, but it was hard to find the frequency where all the 
RBCs displayed obvious positive DEP reactions.  The results are summarized in 
Table 7.1. 
Overall, as sample cells were suspended in the buffer containing more PBS 
solution, the transition frequency increased and the magnitude of positive DEP force 
on the cells decreased.  Moreover, the rate in the change of transition frequencies of 
RBCs between different suspension buffers was different from that of cancer cells, 
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which led to the transition region overlapping in the buffers containing more PBS 
solution. 
 
Table 7.1.  The DEP response of head / neck cancer cell line (212LN) and RBCs 
in different buffer solutions (FI corresponds to the frequency where first positive 
DEP reaction was observed.  FM corresponds to the frequency where most cells 
showed positive DEP reaction.) 
 
212LN Cells Buffer #1 Buffer #2 Buffer #3 Buffer #4 
FI 50 kHz 120 kHz 140 kHz 210 kHz 
FM 150 kHz 250 kHz 600 kHz Not observable 
     
RBCs Buffer #1 Buffer #2 Buffer #3 Buffer #4 
FI 150 kHz 250 kHz 400 kHz 500 kHz 
FM 250 kHz 350 kHz 500 kHz Not observable 
 
Head / neck cancer cells separation from human blood cells were conducted 
using the DEP microsystem described in Chapter 6.  Buffer #1 was used as both 
sheath flow buffer and cell-suspending media.  Two different sets of experiments 
using different frequencies and burst conditions were performed to separate the 
cancer cells from the cancer-spiked whole blood sample.  First set of experiments 
used a 300 KHz, 8 Vp-p AC signal supplied in burst mode (0.217 second ON and 
1.033 second OFF).  Second set of experiments used a 400 KHz, 8 Vp-p AC signal 
supplied in burst mode (0.225 second ON and 0.975 second OFF).  The volumetric 
flow rate of the sample was 20.0 µL/hr and the densities of the cancer cells and blood 
cells were 2.0 × 10
3
 cells/µL and 2.5 × 10
4




Figure 7.8.  Mixed cells flow in the laminar flow without external electric signal 
(a) and head / neck cancer cells separation from human whole blood with 
external electric field. 
 
 Using the stated experimental condition, the cancer cells experienced small 
amount of positive DEP forces and traveled in the laminar flow direction and were 
collected into outlet #2.  Most blood cells demonstrated positive DEP attraction to the 
electrode edges and moved toward outlet #1.  Figure 7.8 shows images of the cell 
separation in the microsystem.  The separation efficiency was measured by counting 
the cancer cells passing through each outlet.  With the first experimental condition, 
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88.30 ± 1.54 % of the cancer cells traveled in the laminar flow direction and were 
collected into outlet #2, while about 95 % of blood cells were deflected from the 
original flow direction and collected into outlet #1.  With the second experimental 
condition, 90.20 ± 1.17 % of the cancer cells traveled in the laminar flow direction 
and were collected into outlet #2, while about 89 % of blood cells were deflected 
from the original flow direction and collected into outlet #1.   
The measured crossover frequencies of the cancer cells in the media with 
different conductivities were lower than those of the blood cells.  Therefore, it was 
expected that during the separation experiments at the frequency higher than the 
crossover frequencies of the head / neck cancer cells and blood cells, the cancer cells 
would be more affected by positive DEP force and deflected into outlet #1, while 
blood cells would be collected into outlet #2.  However, it was found that the lateral 
displacement of the head / neck cancer cells was smaller than that of blood cells when 
the cells were flowing continuously in the laminar flow.  One possible explanation of 
these results is that the volumetric mass density of head / neck cancer cells is lower 
than that of blood cells so that when the cells are flowing in the suspending media, 
the cancer cells stay higher than the blood cells.  To verify this assumption, the 
relative velocity of cancer cells and blood cells flowing in the laminar flow without 
any external electric signal was monitored, and it was observed that the cancer cells 
flew much faster than the blood cells. 
  The continuous flow dielectrophoretic microseparation system has 
successfully demonstrated the ability to separate the cancer cells from human whole 
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blood cells in continuous fashion and can be used as the downstream separation 























CHAPTER 8  
FUTURE MICROSYSTEM DEVELOPMENT 
 
8.1 Introduction 
The complete and permanent removal of cancerous tumors from patients with 
no or little damage to the healthy parts of the body is the ultimate goal of cancer 
therapies.  When diagnosed with cancer, patients usually go through a series of cancer 
treatments, including surgery, chemotherapy, and radiation therapy.  Chemotherapy is 
a method of treating a disease by killing target cells using chemicals.  Most 
chemotherapeutic drugs target fast dividing cells like cancerous cells, but the 
effectiveness of chemotherapy is often limited by its toxicity, or damage to normal 
tissues like cells in hair follicles, the blood, and the digestive tract.  This damage 
often leads to hair loss, gastrointestinal distress, depression of the immune system, 
and even liver / kidney damage. 
Radiation therapy uses ionizing radiation to control cancerous tumors by 
damaging the DNA of cells.  Since oxygen is a potent radiosensitizer that increases 
the effectiveness of radiation therapy, the major limitation of radiation therapy is 
cellular access to oxygen, tumors that are in low-oxygen areas do not respond as well 
to radiation.  Surgery can easily remove a lump of cancer cells, but does nothing to 
limit metastasis, and can’t capture circulating tumor cells, which can allow the cancer 
to spread.  Therefore, in the treatment of cancer, removing circulating tumor cells 
from whole blood can be advantageous.  As stated earlier in Chapter 1, detecting 
CTCs in blood can be used as an early detection methodology for cancer and 
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determining the level of CTCs in blood can be helpful in characterizing genetic and 
immunophenotypic changes with tumor progression. 
However, it is quite challenging to identify and remove only malignant tumor 
cells from peripheral blood without disturbing normal blood cells.  First, cancerous 
cells are constantly shed into the blood stream while the primary tumor cells are still 
active.  Therefore, for successful cancer treatment, it is also required to remove 
malignant tumor cells while doing a whole blood CTC removal process.  Secondly, 
since normal blood cells should be returned back to the peripheral blood and perform 
their assigned roles after the separation process, chemical modification or molecular 
tagging methods of target cancerous cells, which would damage or disturb blood cells 
from their original function, cannot be used in this application.  Another major 
challenge in separating out target cancerous cells in blood arises from the fact that 
human whole blood is heterogeneous mixture of diverse blood cells and 98% of blood 
cells are RBCs whose cell density is around 5 × 10
6
 cells / µL while the cell density 
of CTCs in peripheral blood ranges from 0-1 cells per milliliter, which is extremely 
low compared to that of RBCs.    
In Chapter 3, the magnetophoretic microfluidic system was presented along 
with its design, fabrication and characterization for RBCs removal from a human 
whole blood sample.  The six-stage cascade paramagnetic mode magnetophoretic 
separation system removed RBCs successfully in continuous fashion without 
chemical modification or molecular tagging of the blood sample.  In Chapter 6 and 7, 
the dielectrophoretic microsystem has demonstrated its ability to switch a massive 
blood cells stream from one outlet to the other and to separate different types of cells 
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based on their native dielectric properties in continuous flow.  Malignant head / neck 
cancer cells were characterized for their dielectric properties and shown to have quite 
different dielectrophoretic crossover frequencies from those of normal blood cells.   
Based on the characterization results of the presented magnetophoretic and 
dielectrophoretic separation systems, a magnetophoresis system cascaded with a 
dielectrophoresis system could potentially enable efficient and novel separation of 
target rare cells from human whole blood.  Continuous flow magnetophoresis could 
be used in stage one as an enrichment device for separating most RBCs from a human 
whole blood sample, concentrating target rare cells and other nucleated blood cells.  
In stage two, integrated continuous flow dielectrophoresis could be used as an 
isolation device for separating target rare cells out from other nucleated cells and 
residual RBCs.  
In addition to the development of a cascade magnetophoresis – 
dielectrophoresis separation system, there is a need to develop an approach that 
utilizes whole blood as opposed to diluted blood samples.  The ability to process 
whole blood would open the door for use of the cascade system in point-of-care 
applications.  The key to processing whole blood through the cascade system is to 
design the first stage (magnetophoretic separator) for whole blood separations, 
remembering that the second stage, the dielectrophoretic separation stage, is only 
used to classify the nucleated cells from the sample with the red blood cells removed 
by the first stage.  So, if the first stage could process and remove virtually all the 
RBCs, then the second stage would need only to process a much smaller number of 
cells as already demonstrated through the work detailed in Chapter 6 and 7.  
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Therefore, future microsystem development would be focused on the development of 
a magnetophoretic separation system capable of processing whole blood.  Towards 
this end, another magnetophoresis with forty separation stages has been designed and 
will be presented in the following sections. 
 
8.2 Combined Magnetophoretic / Dielectrophoretic Separation System 
Figure 8.1 illustrates the principle operation of the microsystem combining the 
two separation approaches.  The microsystem consists of two sample introduction 
inlets, two magnetophoretic and dielectrophoretic separation stages, two outlets for 
RBCs, one outlet for cancerous cells, and one outlet for normal nucleated cells.   
Blood samples spiked with malignant tumor cells enter the microsystem through two 
inlets, the cells in the sample pass through a six-stage para magnetic mode 
magnetophoretic stage to remove most of the RBCs from the sample.  RBCs or 
magnetic cells experience an attractive magnetophoretic force and move toward a 
center microchannel, while other nucleated cells remain in side microchannels.  The 
removed RBCs are collected into the center outlet encircled by the microfluidic 
channel containing the enriched nucleated cells which are directed into a 
dielectrophoretic separation stage.  In the dielectrophoretic separation stage, 
malignant tumor cells and other nucleated cells experience different DEP forces 
depending on their native dielectric properties, sizes and density.  This leads to the 
separation and collection of malignant tumor cells from other nucleated cells into the 
inner outlet on the right side of the dielectrophoretic stage, while normal nucleated 
blood cells flow into the outer outlet.  The overall design was configured in a way 
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such that the entire device can be placed on a small glass slide the size of a human 
hand.   
 
 




The fabrication of the combined continuous flow microseparator requires 
three photolithography steps.  Three mask layers for the microfluidic channels, 
electroplated ferromagnetic structures, and comb-shaped electrodes are shown in 
Figure 8.2.  In the design of the microsystem, there are two mirror-imaged 
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magnetophoretic and dielectrophoretic separation chambers placed on one glass slides 




Figure 8.2. Mask designs for microfluidic channel (top), electroplated 
ferromagnetic structures (center), and comb-shaped electrodes (bottom).  
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8.3 Magnetophoretic System for Whole Blood Processing 
Figure 8.3 shows the overview and operation principle of the 40 stage 
magnetophoresis separation system design.  The 40 stage design should allow for 
processing of samples with a much denser population of suspended cells by providing 
a much greater number of collection channels for unwanted RBCs.  The design of the 
ferromagnetic structures were modified to more efficiently attract RBCs from the 
main blood sample stream and release the RBCs easily into the subsequent RBC 
collection channels using the dragging force of laminar flow.   
 
 
Figure 8.3. Design overview and operational principle of the multiple stage 
magnetophoresis microsystem. 
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The design of the microfluidic channels was revised so that the RBC 
collection channels from each separation stage remain separated until reaching the 
outlet waste reservoir.  The operation principle is similar to that of the previously 
presented blood cell separator.  The RBCs are moved towards the ferromagnetic 
structures by an attractive magnetophoretic force, while other nucleated cells stay in 
the main channel.  The length of the first separation stag is designed to be much 
longer to provide enough trapping-time.  By combining forty separation stages in a 
cascade mode, the RBC level in the main channel will be reduced stage by stage and 
only nucleated cells will be collected in the outlet. The two mask layers for the 
microfluidic channels and electroplated ferromagnetic structures are shown in Figure 




Figure 8.4. Mask designs for microfluidic channel (top) and electroplated 
ferromagnetic structures (bottom).  
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8.4 Microsystem Fabrication and Interface / Packaging 
 The microfluidic interface for the combined continuous flow microseparator 
consists of two inlet ports.  The big center opening in the interface shown in the top 
figure of Figure 8.5 is to provide an opening for the two outlets for malignant tumor 
cells and normal nucleated blood cells, while offering additional bonding areas 
between the interface and the glass chip.  Similarly to the previously described 
interfaces, each port has two rubber O-rings inserted and the interface has a “[” 




Figure 8.5. Microfluidic interface design: combined microseparator (top) and 




Figure 8.6. The drilling guide for combined microsystem (top) and multiple 




The system packaging presented in Chapter 4 is used for both the combined 
microseparator and the new multi-stage magnetophoresis system.  The drilling guide 
design for correct positioning of the inlet / outlet ports and electrical connection / test 
holes in the top glass substrate is shown in Figure 8.6.   
The combined microsystem is composed of microfluidic channels, 
ferromagnetic separation structures, comb-shape planar electrodes, inlet / outlet and 
electric connection holes, and microfluidic interfaces.  The overall fabrication process 
of the microseparator is more complicated than those of previously presented 
microsystems since it has both magnetophoresis and dielectrophoresis components.  
The fabrication process consists of wet etching of the glass substrate for microfluidic 
channels, electroplating of ferromagnetic separation structures, patterning of comb-
shaped planar electrodes, glass-to-glass bonding, glass-to-plastic bonding of the 
microfluidic interfaces, and electric wire bonding to the microsystem.  The overall 
fabrication process is shown in Figure 8.7.  
Layers of sputtered Cr / Au  are used as protective layers along with patterned 
photoresist during a hydrofluoric acid wet etching process to create 50 µm deep 
microfluidic channels as previously described in Chapter 3, 4, 6, and 7.  After 
removing the residual photoresist and metal masking layers, the glass slide with the 
microchannels is cleaned in a piranha solution (Figure 8.7(a)).  Then Ti / Cu / Cr 
electroplating seed layers are sputtered and a mold for the ferromagnetic structures in 
the magnetophoretic separation stage is made with another photolithography step 
using thick photoresist.  The softbake process of thick photoresist is carried out 
identically to the softbake described in Chapter 3 and 4.  Ni / Fe permalloy 
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ferromagnetic structures are electroplated as tall as 50 µm tall as described in Chapter 
4 (Figure 8.7(b)).  
 
 
Figure 8.7. The fabrication process of the combined microsystem.   
 
 
 After removing the thick photoresist molds and seed metal layers, another Cr 
/ Au layers for planar electrodes are sputtered with a DC sputterer on the front-side 
surface of the etched glass substrate.  Then, a thick photoresist is used to pattern a 
comb-shape electrode as described in Chapter 6 and 7 (Figure 8.7©).   
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The inlet / outlet holes and electric connection / test holes are drilled using 1.0 
mm / 2.0 mm diamond drill bits in a blank glass slide using an SLA-fabricated 
drilling guide.  The drilled top glass slide is aligned and bonded to the microfluidic 
channel defined bottom glass slide by introducing UV curable adhesive as described 
in previous chapters (Figure 8.7(d)).  A microfluidic interface is bonded to the 
microseparator by repeating the UV curable adhesive bonding process (Figure 8.7(e)).  
Finally, two wires are connected to each contact pad through the electrical connection 
holes using conductive silver paste as described in Chapter 7.  The electrical 
connection is tested by measuring the resistance between the wire end and an electric 
connection test hole. 
Although most of the fabrication steps are similar to that of previously 
developed microsystem, there are several problems expected in the fabrication 
process.  The first one is the problem in the patterning of comb-shaped electrodes.  In 
the development of previous MAP and DEP microsystem, an Au layer was etched 
with iodine-based gold etchant.  However, during a preliminary fabrication, 
electroplated NiFe structures were damaged or weakened in the gold etchant.  
Therefore, new etchant or etching method for the patterning of the electrodes must be 
considered.  Another possible problem is the drilling process for various holes.  The 
drilling process was done with a conventional bench top drill press machine.  
However, the number of holes in the microseparator was almost doubled from the 
previous microsystem, and this increases the possibility of the glass slide shatter in 
the glass drilling.  A drill with higher rotational speeds may be required.   
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The overview of fabrication process of the multiple magnetophoresis system 
is shown in Figure 8.8.  Each fabrication step is identical to that of the previously 
presented microsystem in Chapter 4. 
 
 
Figure 8.8. The fabrication process of the multiple magnetophoresis microsystem.   
 
 
Pictures of the microchannel with electroplating molds are shown in Figure 
8.9.  Before the electroplating process, a Cr layer is removed to expose the Cu layer 
underneath by submerging the device in a 50 % hydrochloric acid solution.  Because 
of the small size of each mold, additional care is needed to prevent bubbles in the 
mold cavity.  Pictures of the electroplated structures on a device before bonding are 
shown in Figure 8.10.  An oblique channel between two electroplated structures is 
shown connected to a RBCs collection channel.  
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Figure 8.9. The picture of the electroplating molds for the multiple 




Figure 8.10. The microfluidic channel with electroplated ferromagnetic 
structures before the bonding process. 
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For the glass-to-glass bonding process, UV curable adhesive bonding was 
tried first.  However, because of the device’s complex microfluidic channels, the 
introduced adhesive blocked one or more microchannel and the bonding process was 
unsuccessful.  A bonding process using PDMS as described in Chapter 4 was also 
tried without an adequate result.  Finally, a thermal glass fusion bonding process was 
carried out.  It gave a better result compared to those with UV adhesive and PDMS 
bonding, but an area of the main channel shown in the top-left image in Figure 8.10 
and areas at the edge of a glass slide were always blocked or narrowed by fused glass 




Figure 8.11. The picture of the microsystem after glass-to-glass bonding (top) 




8.5 Experimental Methods 
The integrated microfluidic system could be tested with a whole blood sample 
spiked with malignant tumor cells.  Human venous blood could be collected into 
evacuated glass tubes, containing EDTA as an anticoagulant.  212LN head / neck 
cancer cells could be used as malignant tumor cells.  The malignant tumor cells could 
be cultured in DMEM / F12 medium (1:1) supplemented with 10 % FBS at 37 °C in a 
humidified atmosphere with 5 % CO2 as described in the previous chapters.  The cells 
could be detached with Cellstripper
TM
 solution following wash / aspiration / 
incubation procedures and collected by centrifugation.  SYTO-13 fluorescent dye 
could be used to identify the tagged cancerous cells during experiments.  For the 
fluorescent tagging, the collected cancer cells could be incubated for additional 2 
hours with SYTO-13 fluorescent dye in an incubator.  The tagged cancer cells could 
be filtered through a cell strainer with a 20 µm mesh size before re-suspending in the 
prepared blood samples.   
Before introducing the sample, the microseparator could be treated similarly 
with a surfactant solution to reduce the adhesion of cells on the microfluidic channel 
surface during the experiments.  The microsystem could be assembled into the SLA 
system packaging presented in Chapter 4 and the attached wires could be connected 
to a function generator.  Two 500 µL gas tight glass syringe could be used to load the 
blood sample spiked with the tumor cells.  A syringe pump capable of pumping two 
syringes at the same flow rate could be used.   
The rare cell isolation of the integrated microsystem is characterized in two ways.  
First, the number of the separated cancer cells is compared to that of the introduced 
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ones to provide rare cell recovery efficiency.  This could be done by counting the 
fluorescent tumor cells in each outlet using video motion capture.  Second, the 
number of normal blood cells in each collection outlet is measured to determine the 
rare cell concentration efficiency.  The number of blood cells could be counted using 
a Coulter Cell Counter.   
The multiple magnetophoresis system could be tested with an identical experimental 


















CHAPTER 9  
CONCLUSIONS AND FUTURE WORK 
 
9.1 Summary 
The objective of my research was to develop microsystem based separation 
technologies for whole cell cancer analysis using human whole blood as the input 
sample.  Two different approaches have been demonstrated; one based on a 
miniaturized cascade magnetophoresis system and a second based on 
dielectrophoresis, both enable efficient and novel separation of targeted rare cells 
from human whole blood.  Both systems can be fabricated using MEMS technologies 
combined with plastic fabrication techniques.  Several versions of the 
magnetophoresis and dielectrophoresis microsystems were designed, fabricated, 
packaged, and characterized for different applications.  Also the design of a 
magnetophoresis and dielectrophoresis integrated continuous flow microseparator 
was presented. 
Each microsystem consisted of microfluidic channels, inlet / outlet ports, 
ferromagnetic structures and / or comb-shaped electrodes, a microfluidic interface, 
and system packaging.  For the operation of each microsystem, a blood or tumor cell 
sample was loaded in a gas-tight glass syringe and introduced into a device through 
Teflon
 TM
 tubing and an SLA-based interface.  In the magnetophoresis system, the 
RBCs or the magnetic cells in the sample experienced a strong magnetophoretic force 
under a non-uniform magnetic field created by external permanent magnets and 
electroplated ferromagnetic structures.  This allowed the RBCs to be separated from 
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the nucleated blood cells or the tagged cells to be separated from the non-magnetic 
cells.  In the dielectrophoresis system, cells with different dielectric properties 
experienced either positive or negative dielectrophoretic force under a non-uniform 
electric field created by an external AC signal and comb-shaped electrodes and 
moved from their original positions in a laminar flow pattern to different positions.  
Several applications for magnetophoresis and dielectrophoresis were demonstrated. 
The first magnetophoresis microsystem, the six-stage cascade paramagnetic 
mode magnetophoretic separation system, was designed and has successfully shown 
high throughput RBC separation from a human whole blood sample.  The overall 
design was based on the previously developed magnetophoresis system and in order 
to optimize the separation throughput and efficiency, several design changes were 
made with theoretical consideration and calculations.  The new design increased the 
throughput of the magnetophoresis system more than four times over the previous 
magnetophoretic separation system.  However, the design changes caused several 
unexpected fabrication problems and required additional efforts.   The increase in the 
depth of the microchannel design required an extra stirring process in the middle of 
the glass wet-etching process.  Also, it created a curing issue because much thicker 
photoresist layer was required for electroplating molds.  The larger area of the 
electroplated ferromagnetic structures made an electroplating process much longer 
and brought about problems such as unevenness in the height between the 
electroplated structures.  Bubble creation in the photoresist molds during the 
electroplating process was another issue that needed to be addressed.  The drilling of 
several holes in a glass slide created another challenge and a drilling guide was used 
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with a drilling machine to solve the issue.  The thermal bonding of two glass slides 
was a major problem as it had broken lots of devices in their final fabrication process, 
and alternative approach using UV curable adhesive for glass-to-glass bonding was 
developed.  The bonding of interface to the glass slide was not huge problem, but it 
was modified for better results.  All the aforementioned problems in the fabrication of 
the microsystem had been solved one by one through trial and error over time.  The 
design of the system packaging was modified several times to ensure better 
experimental conditions.  Later, while doing the experiments, it was found that in 
order to observe cell movements better, the inlet and outlet holes should have been 
placed further away from the main separation chamber, thus the overall design was 
updated.   
The second magnetophoresis microsystem was developed for the isolation of 
malignant cancer cells from benign tumor cells and has successfully separated 
malignant tumor cells tagged with magnetic nanoparticles based on their surface 
expression level of a specific protein from benign tumor cells.  The design of the 
second magnetophoresis system was revised from that of the first one to address the 
specific problems in this application.  The size of the microchannel, the shape of 
ferromagnetic structures, and the number of separation stages were adjusted.  Since 
the magnetic nanoparticle tagged cells showed much higher magnetophoretic force 
than RBCs, for the comparable magnetophoretic force to be applied to the tagged 
cells, the magnetic field intensity needed to be adjusted.  The design of the system 
packaging was changed so that the relative position of permanent magnets to the 
microsystem, thus the magnetic field intensity on the microsystem could be adjusted.  
 149 
Techniques learned during fabrication of the first magnetophoresis system were 
applied to fabrication of the second, and there were no major issues in the 
development of the new magnetophoresis system.  A new bonding method using 
PDMS as a gapping and bonding layer was tried for the case when the ferromagnetic 
structures were over-electroplated.  Head / neck cancer cells were cultured and 
detached from the culture plate later for the experiments.  Unwanted cell cluster often 
caused a microchannel blockage and a cell strainer was used to pre-filter the cancer 
cell sample.  
Both dielectrophoresis systems were developed side by side.  One 
dielectrophoresis system tested its switching and separation capability based on the 
native dielectric properties of different cell types, while the other investigated the 
frequency response of different cell types by measuring their crossover frequencies in 
a medium with different conductivity.  One major problem in the fabrication process 
of the dielectrophoresis system was the electrode disconnection at the edge of the 
microchannel.  Also, the unique design of sheath flow introduction channel, 
encircling the sample inlet hole, created an issue in the bonding process using UV 
curable adhesive.  Initially, the quality of silver paste used to bond wires to contact 
the pads caused much higher electrical resistance between a wire end and an electrical 
connection test hole.  Even after overcoming the fabrication problems, there were 
issues in the experiments such as the electrolysis of water at a low frequency below 1 
kHz, resulting in damage to the electrodes.  In addition, the conductivity of the fluid 
in the separation chamber varied depending on the flow condition of the sheath fluid, 
making separation of target cells complicated because their crossover frequencies 
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changed accordingly.  After all the efforts to solve the problems, the dielectrophoresis 
systems successfully demonstrated their switching and separating capabilities. 
 
9.2 Future Work 
The developed magnetophoresis systems have demonstrated improved 
throughput in the removal of RBC from a human whole blood sample and its 
application to the separation of tagged cancer cells based on their surface expression 
level of a specific protein.  In an effort to improve the throughput of RBC removal, 
another magnetophoresis with 40 separation stages was proposed.  The microsystem 
and its interface were designed and the fabrication process was successful except the 
glass-to-glass bonding process.  The bonding process of the proposed microsystem is 
challenging because of it much complicated microfluidic channel design and resulting 
higher possibility of channel blockage during the bonding process.  For future work, 
the microsystem will be fabricated with a bonding process and tested with an 
undiluted or less diluted human blood sample.   
The dielectrophoresis microsystem has successfully shown the ability to 
switch a blood stream between two outlets and to separate WBCs from a human 
whole blood sample.  Based on the experimental results for the dielectrophoresis 
response of different blood cell types and head / neck cancer cells, the experiments 
separating cancer cells from normal nucleated blood cells was carried out 
successfully.  Han et al. (REF #67) have reported that they separated WBCs from a 
whole blood sample in a high conductive medium, using a difference in the 
magnitude of negative dielectrophoretic forces between various cell types.  For future 
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work, the microsystem will be further investigated with respect to its application to a 
high conductive medium. 
The magnetophoresis and dielectrophoresis integrated system has been 
proposed and designed.  The system could be fabricated considering the possible 
problems previously stated and could be tested for the separation of malignant tumor 
cells from a human blood sample.  The results will probably suggest an update in the 
design of the microsystem as well as the experimental protocol.  An alternative 
flexible material for a device substrate could be sought to investigate its practical 


















Six Stage Cascade Paramagnetic Mode Magnetophoretic Separation System 
Fabrication Process. (Bottom Substrate) 
 
1. Begin with a bare Schott Borofloat glass 
SB-1, 75.0 mm × 20.0 mm × 0.7 mm 
 
2. Informal Cleaning Process 
Submerge in H2SO4:H2O2 (1:1) for 10 min 
 Rinse with DI water 6 times 
 Submerge in HF (50:1) for 30 sec 
 Rinse with DI water 6 times 
 
3. Cr / Au Sputtering (Front and Back sides) 
Equipment: Unifilm Sputter 
Cr nominal deposition rate:  600 Å/min 
Au nominal deposition rate: 800 Å/min 
Cr target thickness: 500 Å  
Au target thickness: 2000 Å  
 
4. 1st Lithography for Microchannel (Shipley 1813 positive) 
Equipment: OAI Mask Aligner 
Spin @ 5000 rpm, 1500 rpm/sec ramp, 30 sec 
Softbake in Oven @ 115 °C for 60 sec 
Expose with H line (405 nm) 
UV intensity: ~ 9 mW/cm
2
  
 Target exposure energy: 150 mJ/cm
2
 
  Expose time: ~ 17 sec 
 Develop with MF 319 
  Develop time: ~20 sec 
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 Rinse with DI water 6 times 
 Paint Back side and perimeter edges  
  Cotton swab soaked with Shipley 1813 
 Hardbake in Oven @ 120 °C for 5 min 
 
5. Au / Cr Etching 
Au etchant: Potassium Iodide 100 g/L and Iodine 25 g/L 
Submerge in Au etchant for 1~2 min 
Inspect front side Cr layer 
Rinse with DI water 6 times 
Submerge in Cr etchant (CR-7) for 1~2 min 
Inspect back side Cr layer 
Rinse with DI water 6 times 
 
6. Glass Etching for Microchannel 
Etching solution for etching two glass slides 
 HF (49 %): 130 mL 
 DI water: 130 mL 
 HNO3: 40 mL 
Submerge the glass slide for 50 min 
Carefully Rinse with DI water 
Submerge the glass slide for additional 20 min 
 Target depth: 100 µm 
Rinse with DI water 6 times 
 
7. Photoresist Removal 
Submerge in hot acetone for 10 min 
Rinse with DI water 6 times 
Submerge in H2SO4:H2O2 (1:1) for 10 min 
 Let both sides exposed to the solution 
Rinse with DI water 6 times 
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8. Au / Cr Etching 
Submerge in Au etchant for 1~2 min 
Rinse with DI water 6 times 
Submerge in Cr etchant for 1~2 min 
Rinse with DI water 6 times 
 
9. Bottom Glass Cleaning 
Submerge in H2SO4:H2O2 (1:1) for 10 min 
 Rinse with DI water 6 times 
 Submerge in HF (50:1) for 30 sec 
 Rinse with DI water 6 times 
 
10. Ti / Cu / Cr Seed Layer Sputtering (Front Side) 
Equipment: Unifilm Sputter 
Ti nominal deposition rate: 300 Å/min 
Ti target thickness: 250 Å 
Cu nominal deposition rate:  800 Å/min 
Cu target thickness: 1200 Å  
Cr nominal deposition rate: 600 Å/min 
Cr target thickness: 1000 Å  
 
11. 2nd Lithography for Ferromagnetic Structures (AZ 9260 positive) 
Equipment: MA-6 Mask Aligner 
Spin @ 300 rpm, 500 rpm/sec ramp, 35 sec 
Photoresist Stabilization 
 15 min in an open air 
 15 min in a sealed container 
Softbake on Hot plate @ 110 °C for 20 min 
   Cool down in air for 30 min 
Expose with H line (405 nm: CI2) 
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UV intensity: ~ 18 mW/cm
2
  
 Target exposure energy: 3800 mJ/cm
2
 
  Expose time: ~ 200 sec 
 Develop with AZ 400K: DI (1:2.5) 
  Develop time: ~10 min 
 Rinse with DI water 6 times 
   
12. Shielding Perimeter Edges 
Paint with cotton swab soaked with Shipley 1813 
 
13. Cr Etching 
Cr etchant: HCl: DI (1:1) 
Submerge the device and catalyze by using an Al foil 
Rinse with DI water  
 
14. NiFe Electroplating 
Electroplating Bath 
 Nickel Sulfate (NiSO4 6H2O): 200 g/L 
 Ferrous Sulfate (FeSO4 7H2O): 8 g/L 
 Nickel Chloride (NiCl2 6 H2O): 5 g/L 
 Boric Acid (H3BO3): 25 g/L 
 Saccharin (C7H5NO3S ): 3 g/L 
 Nickel anode, pH: 4, Temp: 20~25 °C 
Current: 20 mA 
Process time: ~ 10 hrs 
Switch contact side after 5, 5, 10, 10, 15, 15, 30, 30, 60, 60, 90, 
90, 90, and 90 min 
Cover the submerged contact with blue tape. 
 
15. PR Removal 
Submerge in hot acetone for 5 min 
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Rinse with DI water 6 times 
Submerge in hot acetone for 5 min 
Rinse with DI water 6 times 
 
16. Mechanically Peel off the NiFe electroplated on the perimeter edges 
  
17. Ti / Cu / Cr Etching 
Cr etchant: HCl: DI (1:1) 
Submerge and catalyze by using an Al foil 
Rinse with DI water 6 times 
Cu etchant: Cupric Sulfate in Ammonium Hydroxide 
Submerge in Cu etchant for 1 min 
Rinse with DI water 6 times 
Ti etchant: HF (10:1) 
Submerge in Ti etchant for 5 sec 
Rinse with DI water 6 times 
 
18. Glass Surface Cleaning 
Submerge in HF (50:1) for 30 sec 















The Dielectrophoresis Separation System Fabrication Process. 
(Bottom Substrate) 
 
1. Begin with a bare Schott Borofloat glass 
SB-1, 75.0 mm × 20.0 mm × 0.7 mm 
 
2. Informal Cleaning Process 
Submerge in H2SO4:H2O2 (1:1) for 10 min 
 Rinse with DI water 6 times 
 Submerge in HF (50:1) for 30 sec 
 Rinse with DI water 6 times 
 
3. Cr / Au Sputtering (Front and Back sides) 
Equipment: Unifilm Sputter 
Cr nominal deposition rate:  600 Å/min 
Au nominal deposition rate: 800 Å/min 
Cr target thickness: 500 Å  
Au target thickness: 2000 Å  
 
4. 1st Lithography for Microchannel (Shipley 1813 positive) 
Equipment: OAI Mask Aligner 
Spin @ 5000 rpm, 1500 rpm/sec ramp, 30 sec 
Softbake in Oven @ 115 °C for 60 sec 
Expose with H line (405 nm) 
UV intensity: ~ 9 mW/cm
2
  
 Target exposure energy: 150 mJ/cm
2
 
  Expose time: ~ 17 sec 
 Develop with MF 319 
  Develop time: ~20 sec 
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 Rinse with DI water 6 times 
 Paint Back side and perimeter edges  
  Cotton swab soaked with Shipley 1813 
 Hardbake in Oven @ 120 °C for 5 min 
 
5. Au / Cr Etching 
Au etchant: Potassium Iodide 100 g/L and Iodine 25 g/L 
Submerge in Au etchant for 1~2 min 
Inspect front side Cr layer 
Rinse with DI water 6 times 
Submerge in Cr etchant (CR-7) for 1~2 min 
Inspect back side Cr layer 
Rinse with DI water 6 times 
 
6. Glass Etching for Microchannel 
Etching solution for etching two glass slides 
 HF (49 %): 130 mL 
 DI water: 130 mL 
 HNO3: 40 mL 
Submerge the glass slide for 28 min 
Rinse with DI water 6 times 
 
7. Photoresist Removal 
Submerge in hot acetone for 10 min 
Rinse with DI water 6 times 
Submerge in H2SO4:H2O2 (1:1) for 10 min 
 Let both sides exposed to the solution 
Rinse with DI water 6 times 
 
8. Au / Cr Etching 
Submerge in Au etchant for 1~2 min 
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Rinse with DI water 6 times 
Submerge in Cr etchant for 1~2 min 
Rinse with DI water 6 times 
 
9. Bottom Glass Cleaning 
Submerge in H2SO4:H2O2 (1:1) for 10 min 
 Rinse with DI water 6 times 
 Submerge in HF (50:1) for 30 sec 
 Rinse with DI water 6 times 
 
10. Cr / Au Sputtering (Front sides 
Equipment: Unifilm Sputter 
Cr nominal deposition rate:  600 Å/min 
Au nominal deposition rate: 800 Å/min 
Cr target thickness: 500 Å  
Au target thickness: 2500 Å  
 
11. 2nd Lithography for Ferromagnetic Structures (AZ 9260 positive) 
Equipment: MA-6 Mask Aligner 
Spin @ 300 rpm, 500 rpm/sec ramp, 35 sec 
Photoresist Stabilization 
 15 min in an open air 
 15 min in a sealed container 
Softbake on Hot plate @ 110 °C for 20 min 
   Cool down in air for 30 min 
Expose with H line (405 nm: CI2) 
UV intensity: ~ 18 mW/cm
2
  
 Target exposure energy: 3800 mJ/cm
2
 
  Expose time: ~ 200 sec 
 Develop with AZ 400K: DI (1:2.5) 
  Develop time: ~10 min 
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 Rinse with DI water 6 times 
12. Au / Cr Etching 
Submerge in Au etchant for 1~2 min 
Rinse with DI water 6 times 
Submerge in Cr etchant for 1~2 min 
Rinse with DI water 6 times 
 
13. PR Removal 
Submerge in hot acetone for 5 min 
Rinse with DI water 6 times 
Submerge in hot acetone for 5 min 

























 [1] M. Heron, D. L. Hoyert, S. L. Murphy, J. Xu, K. D. Kochanek, and B. Tejada-
Vera, “Deaths: Final Data for 2006,” National Vital Statistics Reports, vol. 57, 
No. 14, April 2009.  
 
[2] American Cancer Society, Cancer Prevention & Early Detection Facts & 
Figures 2009. Atlanta, GA: American Cancer Society, 2009. 
 
[3] American Cancer Society, Cancer Statistics 2009 Presentation. Atlanta, GA: 
American Cancer Society, 2009. 
 
[4] M. J. Horner, L. A. G. Ries, M. Krapcho, N. Neyman, R. Aminou, N. 
Howlader, S. F. Altekruse, E. J. Feuer, L. Huang, A. Mariotto, B. A. Miller, D. 
R. Lewis, M. P. Eisner, D. G. Stinchcomb, and B. K. Edwards.  SEER Cancer 
Statistics Review, 1975-2006, National Cancer Institute. 
http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data 
submission, posted to the SEER web site, 2009. 
 
[5] “Screening and Testing to Detect Cancer,” 
http://www.cancer.gov/cancertopics/screening, Oct. 20, 2009. 
 
[6] D. W. Fairbairn, P. L. Olive, and K. L. Oneill, "THE COMET ASSAY - A 
COMPREHENSIVE REVIEW," Mutation Research-Reviews in Genetic 
Toxicology, vol. 339, pp. 37-59, Feb 1995. 
 
[7] M. Hollstein, D. Sidransky, B. Vogelstein, and C. C. Harris, "P53 
MUTATIONS IN HUMAN CANCERS," Science, vol. 253, pp. 49-53, Jul 
1991. 
 
[8] B. T. Kurien and R. H. Scofield, "Protein blotting: a review," Journal of 
Immunological Methods, vol. 274, pp. 1-15, Mar 2003. 
 
 [9] E. Stockert, E. Jager, Y. T. Chen, M. J. Scanlan, I. Gout, J. Karbach, M. 
Arand, A. Knuth, and L. J. Old, "A survey of the humoral immune response of 
cancer patients to a panel of human tumor antigens," Journal of Experimental 
Medicine, vol. 187, pp. 1349-1354, Apr 1998. 
 
[10] T. J. McDonnell, P. Troncoso, S. M. Brisbay, C. Logothetis, L. W. K. Chung, 
J. T. Hsieh, S. M. Tu, and M. L. Campbell, "EXPRESSION OF THE 
PROTOONCOGENE BCL-2 IN THE PROSTATE AND ITS 
ASSOCIATION WITH EMERGENCE OF ANDROGEN-INDEPENDENT 
PROSTATE-CANCER," Cancer Research, vol. 52, pp. 6940-6944, Dec 1992. 
 
 162 
[11] H. J. Issaq, T. D. Veenstra, T. P. Conrads, and D. Felschow, "The SELDI-
TOF MS approach to proteomics: Protein profiling and biomarker 
identification," Biochemical and Biophysical Research Communications, vol. 
292, pp. 587-592, Apr 2002. 
 
[12] J. Villanueva, J. Philip, D. Entenberg, C. A. Chaparro, M. K. Tanwar, E. C. 
Holland, and P. Tempst, "Serum peptide profiling by magnetic particle-
assisted, automated sample processing and MALDI-TOF mass spectrometry," 
Analytical Chemistry, vol. 76, pp. 1560-1570, Mar 2004. 
 
[13]  G. MacBeath, "Protein microarrays and proteomics," Nature Genetics, vol. 32, 
pp. 526-532, Dec 2002. 
 
[14] S. Spisak, Z. Tulassay, B. Molnar, and A. Guttman, "Protein microchips in 
biomedicine and biomarker discovery," Electrophoresis, vol. 28, pp. 4261-
4273, Dec 2007. 
 
[15]   N. Ramalingam, H. B. Liu, C. C. Dai, Y. Jiang, H. Wang, Q. H. Wang, K. M. 
Hui, and H. Q. Gong, "Real-time PCR array chip with capillary-driven sample 
loading and reactor sealing for point-of-care applications," Biomedical 
Microdevices, vol. 11, pp. 1007-1020, Oct 2009. 
 
[16]  C. S. Zhang and D. Xing, "Miniaturized PCR chips for nucleic acid 
amplification and analysis: latest advances and future trends," Nucleic Acids 
Research, vol. 35, pp. 4223-4237, 2007. 
 
[17] M. Geear, R. R. A. Syms, S. Wright, and A. S. Holmes, "Monolithic MEMS 
quadrupole mass spectrometers by deep silicon etching," Journal of 
Microelectromechanical Systems, vol. 14, pp. 1156-1166, Oct 2005. 
 
[18] N. Sillon and R. Baptist, "Micromachined mass spectrometer," Sensors and 
Actuators B: Chemical, vol. 83,  pp. 129-137, 2002. 
 
[19] P. Arenkov, A. Kukhtin, A. Gemmell, S. Voloshchuk, V. Chupeeva, and A. 
Mirzabekov, "Protein microchips: Use for immunoassay and enzymatic 
reactions," Analytical Biochemistry, vol. 278, pp. 123-131, Feb 2000. 
 
[20] H. Zhu, M. Bilgin, R. Bangham, D. Hall, A. Casamayor, P. Bertone, N. Lan, R. 
Jansen, S. Bidlingmaier, T. Houfek, T. Mitchell, P. Miller, R. A. Dean, M. 
Gerstein, and M. Snyder, "Global analysis of protein activities using proteome 
chips," Science, vol. 293, pp. 2101-2105, Sep 2001. 
 
 [21] D. K. Chatterjee, K. Sitaraman, C. Baptista, J. Hartley, T. M. Hill, and D. J. 
Munroe, "Protein Microarray On-Demand: A Novel Protein Microarray 
System," Plos One, vol. 3, p. 5, Sep 2008. 
 
 163 
[22] G. MacBeath, "Protein microarrays and proteomics," Nature Genetics, vol. 32, 
pp. 526-532, Dec 2002. 
 
[23]  W. J. Allard, J. Matera, M. C. Miller, M. Repollet, M. C. Connelly, C. Rao, A. 
G. J. Tibbe, J. W. Uhr, and L. Terstappen, "Tumor cells circulate in the 
peripheral blood of all major carcinomas but not in healthy subjects or patients 
with nonmalignant diseases," Clinical Cancer Research, vol. 10, pp. 6897-
6904, Oct 2004. 
 
[24]  W. A. Bonner, R. G. Sweet, H. R. Hulett, and Herzenbe.La, 
"FLUORESCENCE ACTIVATED CELL SORTING," Review of Scientific 
Instruments, vol. 43, pp. 404-&, 1972. 
 
[25]  L. A. Herzenberg, D. Parks, B. Sahaf, O. Perez, M. Roederer, and L. A. 
Herzenberg, "The history and future of the fluorescence activated cell sorter 
and flow cytometry: A view from Stanford," Clinical Chemistry, vol. 48, pp. 
1819-1827, Oct 2002. 
 
[26]  A. Y. Fu, C. Spence, A. Scherer, F. H. Arnold, and S. R. Quake, "A 
microfabricated fluorescence-activated cell sorter," Nature Biotechnology, vol. 
17, pp. 1109-1111, Nov 1999. 
 
[27]  S. Sergent-Tanguy, C. Chagneau, I. Neveu, and P. Naveilhan, "Fluorescent 
activated cell sorting (FACS): a rapid and reliable method to estimate the 
number of neurons in a mixed population," Journal of Neuroscience Methods, 
vol. 129, pp. 73-79, Oct 2003. 
 
[28]  Y. Ito and K. Shinomiya, "A new continuous-flow cell separation method 
based on cell density: Principle, apparatus, and preliminary application to 
separation of human buffy coat," Journal of Clinical Apheresis, vol. 16, pp. 
186-191, 2001. 
 
[29]  H. Shiono and Y. Ito, "Novel method for continuous cell separation by density 
gradient centrifugation: Evaluation of a miniature separation column," 
Preparative Biochemistry & Biotechnology, vol. 33, pp. 87-100, 2003. 
 
[30] A. V. Quirk and J. R. Woodrow, "TANGENTIAL FLOW FILTRATION - A 
NEW METHOD FOR THE SEPARATION OF BACTERIAL ENZYMES 
FROM CELL DEBRIS," Biotechnology Letters, vol. 5, pp. 277-282, 1983. 
 
[31]  J. Fluitman, "Microsystems technology: Objectives," Sensors and Actuators 
a-Physical, vol. 56, pp. 151-166, Aug 1996. 
 
[32]  C. C. Liu and Z. H. Jin, "Applications of microfabrication and 
micromachining techniques to biotechnology," Trends in Biotechnology, vol. 
15, pp. 213-216, Jun 1997. 
 164 
 
[33] D. V. McAllister, M. G. Allen, and M. R. Prausnitz, "Microfabricated 
microneedles for gene and drug delivery," Annual Review of Biomedical 
Engineering, vol. 2, pp. 289-313, 2000. 
 
[34]  J. Voldman, M. L. Gray, and M. A. Schmidt, "Microfabrication in biology and 
medicine," Annual Review of Biomedical Engineering, vol. 1, pp. 401-425, 
1999. 
 
[35] J. El-Ali, P. K. Sorger, and K. F. Jensen, "Cells on chips," Nature, vol. 442, 
pp. 403-411, Jul 2006. 
 
[36]  N. Pamme, "Continuous flow separations in microfluidic devices," Lab on a 
Chip, vol. 7, pp. 1644-1659, 2007. 
 
[37]  C. D. Chin, V. Linder, and S. K. Sia, "Lab-on-a-chip devices for global health: 
Past studies and future opportunities," Lab on a Chip, vol. 7, pp. 41-57, 2007 
 
[38]  P. Yager, T. Edwards, E. Fu, K. Helton, K. Nelson, M. R. Tam, and B. H. 
Weigl, "Microfluidic diagnostic technologies for global public health," Nature, 
vol. 442, pp. 412-418, Jul 2006. 
 
[39]  A. J. Tudos, G. A. J. Besselink, and R. B. M. Schasfoort, "Trends in 
miniaturized total analysis systems for point-of-care testing in clinical 
chemistry," Lab on a Chip, vol. 1, pp. 83-95, 2001. 
 
[40]  H. Mohamed, L. D. McCurdy, D. H. Szarowski, S. Duva, J. N. Turner, and M. 
Caggana, "Development of a rare cell fractionation device: Application for 
cancer detection," Ieee Transactions on Nanobioscience, vol. 3, pp. 251-256, 
Dec 2004. 
 
[41]  S. Choi, S. Song, C. Choi, and J. K. Park, "Continuous blood cell separation 
by hydrophoretic filtration," Lab on a Chip, vol. 7, pp. 1532-1538, 2007. 
 
[42]  S. Vankrunkelsven, D. Clicq, K. Pappaert, W. Ranson, C. De Tandt, H. 
Ottevaere, H. Thienpont, G. V. Baron, and G. Desmet, "A novel microstep 
device for the size separation of cells," Electrophoresis, vol. 25, pp. 1714-
1722, Jun 2004. 
 
[43]  M. Yamada and M. Seki, "Microfluidic particle sorter employing flow 
splitting and recombining," Analytical Chemistry, vol. 78, pp. 1357-1362, Feb 
2006. 
 
[44]  J. J. Hawkes and W. T. Coakley, "Force field particle filter, combining 
ultrasound standing waves and laminar flow," Sensors and Actuators B-
Chemical, vol. 75, pp. 213-222, May 2001. 
 165 
 
[45]  T. Laurell, F. Petersson, and A. Nilsson, "Chip integrated strategies for 
acoustic separation and manipulation of cells and particles," Chemical Society 
Reviews, vol. 36, pp. 492-506, 2007. 
 
[46]  A. Nilsson, F. Petersson, H. Jonsson, and T. Laurell, "Acoustic control of 
suspended particles in micro fluidic chips," Lab on a Chip, vol. 4, pp. 131-135, 
2004. 
 
[47]  F. Petersson, A. Nilsson, C. Holm, H. Jonsson, and T. Laurell, "Continuous 
separation of lipid particles from erythrocytes by means of laminar flow and 
acoustic standing wave forces," Lab on a Chip, vol. 5, pp. 20-22, 2005. 
 
[48]  F. Petersson, L. Aberg, A. M. Sward-Nilsson, and T. Laurell, "Free flow 
acoustophoresis: Microfluidic-based mode of particle and cell separation," 
Analytical Chemistry, vol. 79, pp. 5117-5123, Jul 2007. 
 
[49]  K. Dholakia, M. P. MacDonald, P. Zemanek, and T. Cizmar, "Cellular and 
colloidal separation using optical forces," in Laser Manipulation of Cells and 
Tissues. vol. 82, 2007, pp. 467-495. 
 
[50]  M. P. MacDonald, S. Neale, L. Paterson, A. Richies, K. Dholakia, and G. C. 
Spalding, "Cell cytometry with a light touch: Sorting microscopic matter with 
an optical lattice," Journal of Biological Regulators and Homeostatic Agents, 
vol. 18, pp. 200-205, Apr-Jun 2004. 
 
[51]  Y. Y. Sun, X. C. Yuan, L. S. Ong, J. Bu, S. W. Zhu, and R. Liu, "Large-scale 
optical traps on a chip for optical sorting," Applied Physics Letters, vol. 90, 
Jan 2007. 
 
[52]  M. Ozkan, M. Wang, C. Ozkan, R. Flynn, A. Birkbeck, and S. Esener, 
"Optical manipulation of objects and biological cells in microfluidic devices," 
Biomedical Microdevices, vol. 5, pp. 61-67, Mar 2003. 
 
[53] Y. H. Lin and G. B. Lee, "Optically induced flow cytometry for continuous 
microparticle counting and sorting," Biosensors & Bioelectronics, vol. 24, pp. 
572-578, Dec 2008. 
 
[54]  M. M. Wang, E. Tu, D. E. Raymond, J. M. Yang, H. C. Zhang, N. Hagen, B. 
Dees, E. M. Mercer, A. H. Forster, I. Kariv, P. J. Marchand, and W. F. Butler, 
"Microfluidic sorting of mammalian cells by optical force switching," Nature 
Biotechnology, vol. 23, pp. 83-87, Jan 2005. 
 
[55]  M. P. MacDonald, G. C. Spalding, and K. Dholakia, "Microfluidic sorting in 
an optical lattice," Nature, vol. 426, pp. 421-424, Nov 2003. 
 
 166 
[56]  R. W. Applegate, J. Squier, T. Vestad, J. Oakey, and D. W. M. Marr, "Optical 
trapping, manipulation, and sorting of cells and colloids in microfluidic 
systems with diode laser bars," Optics Express, vol. 12, pp. 4390-4398, Sep 
2004. 
 
[57]  A. F. Ngomsik, A. Bee, M. Draye, G. Cote, and V. Cabuil, "Magnetic nano- 
and microparticles for metal removal and environmental applications: a 
review," Comptes Rendus Chimie, vol. 8, pp. 963-970, Jun-Jul 2005. 
 
[58]  M. Sarikaya, T. Abbasov, and M. Erdemoglu, "Some aspects of magnetic 
filtration theory for removal of fine particles from aqueous suspensions," 
Journal of Dispersion Science and Technology, vol. 27, pp. 193-198, 2006. 
 
[59]  Richard Gerber and Robert R. Birss High Gradient Magnetic Separation. 
 
[60] A. Ditsch, J. Yin, P. E. Laibinis, D. I. C. Wang, and T. A. Hatton, "Ion-
exchange purification of proteins using magnetic nanoclusters," 
Biotechnology Progress, vol. 22, pp. 1153-1162, Aug 2006. 
 
[61]  G. D. Moeser, K. A. Roach, W. H. Green, P. E. Laibinis, and T. A. Hatton, 
"Water-based magnetic fluids as extractants for synthetic organic 
compounds," Industrial & Engineering Chemistry Research, vol. 41, pp. 
4739-4749, Sep 2002. 
 
[62]  T. E. Thomas, S. J. R. Abraham, A. J. Otter, E. W. Blackmore, and P. M. 
Lansdorp, "HIGH-GRADIENT MAGNETIC SEPARATION OF CELLS ON 
THE BASIS OF EXPRESSION LEVELS OF CELL-SURFACE 
ANTIGENS," Journal of Immunological Methods, vol. 154, pp. 245-252, Oct 
1992. 
 
[63]  A. J. Richards, O. S. Roath, R. J. S. Smith, and J. H. P. Watson, "The 
mechanisms of high gradient magnetic separation of human blood and bone 
marrow," Ieee Transactions on Magnetics, vol. 32, pp. 459-470, Mar 1996. 
 
[64]  B. B. Yellen, Z. G. Forbes, D. S. Halverson, G. Fridman, K. A. Barbee, M. 
Chorny, R. Levy, and G. Friedman, "Targeted drug delivery to magnetic 
implants for therapeutic applications," Journal of Magnetism and Magnetic 
Materials, vol. 293, pp. 647-654, May 2005. 
 
[65]  H. T. Chen, A. D. Ebner, A. J. Rosengart, M. D. Kaminski, and J. A. Ritter, 
"Analysis of magnetic drug carrier particle capture by a magnetizable 
intravascular stent: 1. Parametric study with single wire correlation," Journal 
of Magnetism and Magnetic Materials, vol. 284, pp. 181-194, Dec 2004. 
 
[66]  J. A. Ritter, A. D. Ebner, K. D. Daniel, and K. L. Stewart, "Application of 
high gradient magnetic separation principles to magnetic drug targeting," 
 167 
Journal of Magnetism and Magnetic Materials, vol. 280, pp. 184-201, Sep 
2004. 
 
[67] D. L. Siegel, T. Y. Chang, S. L. Russell, and V. Y. Bunya, "Isolation of cell 
surface-specific human monoclonal antibodies using phage display and 
magnetically-activated cell sorting: applications in immunohematology," 
Journal of Immunological Methods, vol. 206, pp. 73-85, Aug 1997. 
 
[68] D. J. Richel, H. E. Johnsen, J. Canon, T. Guillaume, M. R. Schaafsma, C. 
Schenkeveld, S. W. Hansen, I. McNiece, A. J. Gringeri, R. Briddell, C. Ewen, 
R. Davies, J. Freeman, S. Miltenyi, and M. Symann, "Highly purified 
CD34(+) cells isolated using magnetically activated cell selection provide 
rapid engraftment following high-dose chemotherapy in breast cancer 
patients," Bone Marrow Transplantation, vol. 25, pp. 243-249, Feb 2000. 
 
[69] H. Abts, M. Emmerich, S. Miltenyi, A. Radbruch, and H. Tesch, "CD20 
POSITIVE HUMAN LYMPHOCYTES-B SEPARATED WITH THE 
MAGNETIC CELL SORTER (MACS) CAN BE INDUCED TO 
PROLIFERATION AND ANTIBODY SECRETION INVITRO," Journal of 
Immunological Methods, vol. 125, pp. 19-28, Dec 1989. 
 
[70]  J. T. Kemshead and J. Ugelstad, "MAGNETIC SEPARATION 
TECHNIQUES - THEIR APPLICATION TO MEDICINE," Molecular and 
Cellular Biochemistry, vol. 67, pp. 11-18, 1985. 
 
[71]  V. M. Martin, C. Siewert, A. Scharl, T. Harms, R. Heinze, S. Ohl, A. 
Radbruch, S. Miltenyi, and J. Schmitz, "Immunomagnetic enrichment of 
disseminated epithelial tumor cells from peripheral blood by MACS," 
Experimental Hematology, vol. 26, pp. 252-264, Mar 1998. 
 
[72]  S. Miltenyi, W. Muller, W. Weichel, and A. Radbruch, "HIGH-GRADIENT 
MAGNETIC CELL-SEPARATION WITH MACS," Cytometry, vol. 11, pp. 
231-238, 1990. 
 
[73]  E. Schulze, C. Siewert, M. Herber, J. Schmitz, M. Assenmacher, and S. 
Miltenyi, "Highly sensitive detection of disseminated tumor cells using MACS 
technology," Cytometry, vol. 46, pp. 193-194, Jun 2001. 
 
[74]  C. Siewert, M. Herber, N. Hunzelmann, O. Fodstad, S. Miltenyi, M. 
Assenmacher, and J. Schmitz, "Rapid enrichment and detection of melanoma 
cells from PBMC by a new assay combining immunomagnetic cell sorting and 
immunocytochemical staining," Journal of Investigative Dermatology, vol. 
113, pp. 512-512, Sep 1999. 
 
 168 
[75]  M. Takayasu, N. Duske, S. R. Ash, and F. J. Friedlaender, "HGMS STUDIES 
OF BLOOD-CELL BEHAVIOR IN PLASMA," Ieee Transactions on 
Magnetics, vol. 18, pp. 1520-1522, 1982. 
 
[76] K. H. Han, A. Han, and A. B. Frazier, "Microsystems for isolation and 
electrophysiological analysis of breast cancer cells from blood," Biosensors & 
Bioelectronics, vol. 21, pp. 1907-1914, Apr 2006. 
 
[77]  K. H. Han and A. B. Frazier, "Paramagnetic capture mode magnetophoretic 
microseparator for blood cells," Iee Proceedings-Nanobiotechnology, vol. 153, 
pp. 67-73, Aug 2006. 
 
[78]  M. Zborowski, G. R. Ostera, L. R. Moore, S. Milliron, J. J. Chalmers, and A. 
N. Schechter, "Red blood cell magnetophoresis," Biophysical Journal, vol. 84, 
pp. 2638-2645, Apr 2003. 
 
[79] M. Takayasu, D. R. Kelland, and J. V. Minervini, "Continuous magnetic 
separation of blood components from whole blood," Ieee Transactions on 
Applied Superconductivity, vol. 10, pp. 927-930, Mar 2000. 
 
[80]  N. Pamme and C. Wilhelm, "Continuous sorting of magnetic cells via on-chip 
free-flow magnetophoresis," Lab on a Chip, vol. 6, pp. 974-980, 2006. 
 
[81]  N. Xia, T. P. Hunt, B. T. Mayers, E. Alsberg, G. M. Whitesides, R. M. 
Westervelt, and D. E. Ingber, "Combined microfluidic-micromagnetic 
separation of living cells in continuous flow," Biomedical Microdevices, vol. 8, 
pp. 299-308, Dec 2006. 
 
[82]  K. H. Han and A. B. Frazier, "Continuous magnetophoretic separation of blood 
cells in microdevice format," Journal of Applied Physics, vol. 96, pp. 5797-
5802, Nov 2004. 
 
[83] M. Toner and D. Irimia, "Blood-on-a-chip," Annual Review of Biomedical 
Engineering, vol. 7, pp. 77-103, 2005. 
 
[84] Y. S. Chang, E. di Tomaso, D. M. McDonald, R. Jones, R. K. Jain, and L. L. 
Munn, "Mosaic blood vessels in tumors: Frequency of cancer cells in contact 
with flowing blood," Proceedings of the National Academy of Sciences of the 
United States of America, vol. 97, pp. 14608-14613, Dec 2000. 
 
[85]  S. Mocellin, U. Keilholz, C. R. Rossi, and D. Nitti, "Circulating tumor cells: 
the 'leukemic phase' of solid cancers," Trends in Molecular Medicine, vol. 12, 
pp. 130-139, Mar 2006. 
 
 169 
[86] K. H. Han and A. B. Frazier, "Diamagnetic capture mode magnetophoretic 
microseparator for blood cells," Journal of Microelectromechanical Systems, 
vol. 14, pp. 1422-1431, Dec 2005. 
 
[87]  K. H. Han and A. B. Frazier, "Reliability aspects of packaging and integration 
technology for microfluidic systems," Ieee Transactions on Device and 
Materials Reliability, vol. 5, pp. 452-457, Sep 2005. 
 
[88] A. B. Frazier, "Metallic microstructures fabricated using photosensitive 
polyimide electroplating molds," Journal of Microelectromechanical Systems, 
vol. 2, pp. 87-94, 1993. 
 
[89] D. A. Colling, "INTRINSIC MAGNETIZATION OF FE-NI-MN ALLOYS," 
Journal of Applied Physics, vol. 40, pp. 1379-&, 1969. 
 
[90] R. Marhaba, P. Klingbeil, T. Nuebel, I. Nazarenko, M. W. Buechler, and M. 
Zoeller, "CD44 and EpCAM: Cancer-Initiating Cell Markers," Current 
Molecular Medicine, vol. 8, pp. 784-804, Dec 2008. 
 
[91] L. J. Harper, K. Piper, J. Common, F. Fortune, and I. C. Mackenzie, "Stem 
cell patterns in cell lines derived from head and neck squamous cell 
carcinoma," Journal of Oral Pathology & Medicine, vol. 36, pp. 594-603, 
Nov 2007. 
 
[92] C. Brakebusch and R. Fassler, "beta 1 integrin function in vivo: Adhesion, 
migration and more," Cancer and Metastasis Reviews, vol. 24, pp. 403-411, 
Sep 2005. 
 
[93] M. D. Basson, "An intracellular signal pathway that regulates cancer cell 
adhesion in response to extracellular forces," Cancer Research, vol. 68, pp. 2-
4, Jan 2008. 
 
[94] H. A. Pohl, Dielectrophoresis. New York: Cambridge University Press, 1978. 
 
[95] H. A. Pohl, "SOME EFFECTS OF NONUNIFORM FIELDS ON 
DIELECTRICS," Journal of Applied Physics, vol. 29, pp. 1182-1188, 1958. 
 
[96] P. R. C. Gascoyne and J. Vykoukal, "Particle separation by dielectrophoresis," 
Electrophoresis, vol. 23, pp. 1973-1983, Jul 2002. 
 
[97] H. A. Pohl and I. Hawk, "SEPARATION OF LIVING AND DEAD CELLS 
BY DIELECTROPHORESIS," Science, vol. 152, pp. 647-&, 1966. 
 
[98] F. F. Becker, X. B. Wang, Y. Huang, R. Pethig, J. Vykoukal, and P. R. C. 
Gascoyne, "SEPARATION OF HUMAN BREAST-CANCER CELLS FROM 
BLOOD BY DIFFERENTIAL DIELECTRIC AFFINITY," Proceedings of 
 170 
the National Academy of Sciences of the United States of America, vol. 92, pp. 
860-864, Jan 1995. 
 
[99] J. S. Crane and H. A. Pohl, "A STUDY OF LIVING AND DEAD YEAST 
CELLS USING DIELECTROPHORESIS," Journal of the Electrochemical 
Society, vol. 115, pp. 584-&, 1968. 
 
[100] G. H. Markx, M. S. Talary, and R. Pethig, "SEPARATION OF VIABLE 
AND NONVIABLE YEAST USING DIELECTROPHORESIS," Journal of 
Biotechnology, vol. 32, pp. 29-37, Jan 1994. 
 
[101] C. H. Tai, S. K. Hsiung, C. Y. Chen, M. L. Tsai, and G. B. Lee, "Automatic 
microfluidic platform for cell separation and nucleus collection," Biomedical 
Microdevices, vol. 9, pp. 533-543, Aug 2007. 
 
[102] M. D. Vahey and J. Voldman, "An equilibrium method for continuous-flow 
cell sorting using dielectrophoresis," Analytical Chemistry, vol. 80, pp. 3135-
3143, May 2008. 
 
[103] M. S. Pommer, Y. T. Zhang, N. Keerthi, D. Chen, J. A. Thomson, C. D. 
Meinhart, and H. T. Soh, "Dielectrophoretic separation of platelets from 
diluted whole blood in microfluidic channels," Electrophoresis, vol. 29, pp. 
1213-1218, Mar 2008. 
 
[104] Y. L. Li, C. Dalton, H. J. Crabtree, G. Nilsson, and K. Kaler, "Continuous 
dielectrophoretic cell separation microfluidic device," Lab on a Chip, vol. 7, 
pp. 239-248, 2007.  
 
[105] I. Doh and Y. H. Cho, "A continuous cell separation chip using hydrodynamic 
dielectrophoresis (DEP) process," Sensors and Actuators a-Physical, vol. 121, 
pp. 59-65, May 2005. 
 
[106] K. H. Han and A. B. Frazier, "Lateral-driven continuous dielectrophoretic 
microseparators for blood cells suspended in a highly conductive medium," 
Lab on a Chip, vol. 8, pp. 1079-1086, 2008. 
 
 
 
